setID	setSize	setScore	N	setP	setQ	setName	setID.orig
1062	596	48.0035721527581	596	0	0	Hemostasis	709
1278	328	51.3009565545772	328	0	0	Neuronal System	1045
339	197	46.0886996454528	197	1e-04	0.0199337160289028	Proteoglycans in cancer	1276
477	26	20.9969477990453	26	1e-04	0.0199337160289028	Glypican 1 network	676
560	31	21.8994422350682	31	1e-04	0.0199337160289028	Syndecan-4-mediated signaling events	1641
1318	18	17.1879190090797	18	1e-04	0.0199337160289028	Other semaphorin interactions	1119
169	86	29.5001707296322	86	2e-04	0.0299005740433542	Dilated cardiomyopathy	404
1416	33	22.1479438173427	33	2e-04	0.0299005740433542	Purine metabolism (REACTOME)	1282
685	519	14.8932527528357	519	3e-04	0.0326188080472955	Axon guidance (REACTOME)	162
1378	263	38.9026279064906	263	3e-04	0.0326188080472955	Platelet activation, signaling and aggregation	1214
1628	108	31.0292460834126	108	3e-04	0.0326188080472955	Signaling by NOTCH	1541
240	80	31.5432284142593	80	4e-04	0.0341720846209763	Hypertrophic cardiomyopathy (HCM)	760
293	12	12.6055169575157	12	4e-04	0.0341720846209763	Non-homologous end-joining	1066
778	44	26.3578419815074	44	4e-04	0.0341720846209763	Collagen chain trimerization	307
101	139	35.4454428371206	139	5e-04	0.0398674320578057	Adrenergic signaling in cardiomyocytes	66
128	166	33.6066673531855	166	6e-04	0.0422125751200295	Axon guidance (KEGG)	161
425	46	22.8609592311259	46	6e-04	0.0422125751200295	Angiopoietin receptor Tie2-mediated signaling	99
558	30	18.6059197279361	30	7e-04	0.0440640038533642	Syndecan-2-mediated signaling events	1639
1780	201	33.0689988899886	201	7e-04	0.0440640038533642	Transmission across Chemical Synapses	1775
390	112	26.7909357429493	112	9e-04	0.0538210332780376	Thyroid hormone signaling pathway	1707
1587	64	23.142632443014	64	0.001	0.0569534743682938	Semaphorin interactions	1485
424	30	18.06837564387	30	0.0011	0.0598011480867085	Alpha-synuclein signaling	82
1257	54	22.2927685334119	54	0.0012	0.0624011980035219	NRAGE signals death through JNK	1084
1417	12	12.0948972116637	12	0.0013	0.0647845770939342	Purine ribonucleoside monophosphate biosynthesis	1285
303	20	13.8850185882267	20	0.0015	0.0717613777040502	Other types of O-glycan biosynthesis	1120
566	42	18.791640616877	42	0.0018	0.0824843421885634	Thromboxane A2 receptor signaling	1704
174	80	23.8555683319819	80	0.0019	0.0824843421885634	ECM-receptor interaction	458
514	54	20.5801541334077	54	0.002	0.0824843421885634	PDGFR-beta signaling pathway	1158
1787	100	25.1753095420537	100	0.002	0.0824843421885634	Transport of inorganic cations/anions and amino acids/oligopeptides	1777
399	41	27.2199338647687	41	0.0021	0.0837216073213919	Type I diabetes mellitus	1807
202	74	22.104600738133	74	0.0023	0.0887371874835029	Gastric acid secretion	623
576	27	15.122103816216	27	0.0024	0.089006359943008	Wnt signaling network	1859
526	37	16.9308353771721	37	0.0026	0.089006359943008	Regulation of RAC1 activity	1356
924	282	24.6750697610451	282	0.0028	0.089006359943008	Extracellular matrix organization	516
1655	451	2.71498774295843	451	0.0029	0.089006359943008	Signalling by NGF	1577
1791	37	19.8436111352177	37	0.0029	0.089006359943008	Transport of vitamins, nucleosides, and related molecules	1786
131	55	20.4438514682718	55	0.003	0.089006359943008	Basal cell carcinoma	167
527	42	17.7699300560056	42	0.003	0.089006359943008	Regulation of RhoA activity	1359
85	14	11.3495290458586	14	0.0031	0.089006359943008	Murine Leukemia Virus (ssRNART)	1004
1660	13	11.0614571733897	13	0.0031	0.089006359943008	Sodium/Calcium exchangers	1592
314	381	11.6293638915041	381	0.0032	0.089006359943008	Pathways in cancer	1149
523	29	15.0297703097302	29	0.0032	0.089006359943008	Reelin signaling pathway	1318
1275	10	9.63038516169539	10	0.0032	0.089006359943008	Netrin mediated repulsion signals	1041
43	10	9.33514214037172	10	0.0033	0.0897017221300627	reactive oxygen species degradation	1310
336	84	23.8177519563894	84	0.0039	0.102857974709139	Protein digestion and absorption	1268
726	22	12.8903870369938	22	0.004	0.102857974709139	CTLA4 inhibitory signaling	341
111	91	22.0509853455618	91	0.0042	0.102857974709139	Amoebiasis	92
146	130	26.2023491854974	130	0.0043	0.102857974709139	Cell adhesion molecules (CAMs)	241
308	70	20.9858448420546	70	0.0043	0.102857974709139	PPAR signaling pathway	1238
490	51	18.9276027644524	51	0.0043	0.102857974709139	IL2-mediated signaling events	773
1178	20	13.7242646108256	20	0.0044	0.10318629473785	MET activates PTK2 signaling	927
269	101	20.3339463632402	101	0.0045	0.103501987073149	Melanogenesis	922
1415	10	8.98852468047961	10	0.0046	0.103805766490136	Purine catabolism	1279
248	82	20.1741578599632	82	0.0048	0.104380185751346	Insulin secretion	809
745	69	19.4112475215487	69	0.0048	0.104380185751346	Cell death signalling via NRAGE, NRIF and NADE	246
195	190	18.4878816389242	190	0.0049	0.10465200915174	Focal adhesion	559
677	57	20.7562126565268	57	0.0051	0.105167536290418	Assembly of collagen fibrils and other multimeric structures	137
811	349	4.16154401701074	361	0.0051	0.105167536290418	DAP12 interactions*	363
1363	26	16.3032945599581	26	0.0053	0.107439350799849	Phase 2 - plateau phase	1174
1039	108	19.7624607406678	108	0.0054	0.107642066556075	Golgi-to-ER retrograde transport	680
243	96	20.0401824767321	96	0.006	0.117641602793525	Inflammatory mediator regulation of TRP channels	787
391	72	18.0134778787521	72	0.0067	0.129247642639015	Thyroid hormone synthesis	1708
503	30	13.7801316560776	30	0.007	0.130815011439675	Lissencephaly gene (LIS1) in neuronal migration and development	885
1568	272	11.8609495691952	272	0.007	0.130815011439675	SLC-mediated transmembrane transport	1586
39	10	8.24526067495925	10	0.0074	0.136162614105121	purine nucleotides degradation	1284
464	26	12.3109623123552	26	0.0081	0.14678463621283	Ephrin B reverse signaling	487
870	351	0.405916671045876	351	0.0085	0.149069528563969	Diseases of signal transduction	415
578	48	16.2148993643168	48	0.0086	0.149069528563969	amb2 Integrin signaling	84
1563	22	11.762190381993	22	0.0086	0.149069528563969	SHC1 events in ERBB2 signaling	1497
381	84	18.5375523063795	84	0.0088	0.150357172332296	TGF-beta signaling pathway	1692
276	47	19.7225532315409	47	0.009	0.15116401321918	Mineral absorption	960
1376	13	9.18043580584867	13	0.0091	0.15116401321918	Platelet Adhesion to exposed collagen	1215
1481	16	10.6518313758056	16	0.0094	0.151690717097992	Recycling of bile acids and salts	1315
906	26	12.0531404885574	26	0.0095	0.151690717097992	Effects of PIP2 hydrolysis	459
1548	129	16.4953271582035	135	0.0097	0.151690717097992	Role of LAT2/NTAL/LAB on calcium mobilization*	1454
190	43	14.3858651758637	43	0.0102	0.151690717097992	Fatty acid metabolism	528
242	61	21.1329679290063	61	0.0102	0.151690717097992	Inflammatory bowel disease (IBD)	786
1251	370	-4.16347316894751	370	0.0102	0.151690717097992	NGF signalling via TRKA from the plasma membrane	1055
1361	45	17.5961517260421	45	0.0102	0.151690717097992	Phase 0 - rapid depolarisation	1172
1627	20	11.1050107317513	20	0.0103	0.151690717097992	Signaling by NODAL	1540
191	66	17.4786289833777	66	0.0104	0.151690717097992	Fc epsilon RI signaling pathway	534
999	50	15.514884865177	50	0.0104	0.151690717097992	GPVI-mediated activation cascade	683
1260	18	11.8387597366114	18	0.0107	0.153774380794393	Na+/Cl- dependent neurotransmitter transporters	1019
972	83	15.7062271927243	83	0.0108	0.153774380794393	G alpha (12/13) signalling events	587
780	87	18.3105383300372	87	0.011	0.154370405526155	Collagen formation	309
1498	16	9.75010753629108	16	0.0111	0.154370405526155	Regulation of KIT signaling	1345
1629	69	15.6895093424583	69	0.0114	0.156298455226624	Signaling by NOTCH1	1542
1150	91	18.0984281391939	91	0.0115	0.156298455226624	L1CAM interactions	867
901	15	10.0279709411726	15	0.0117	0.156403002688315	ERBB2 Regulates Cell Motility	501
340	20	10.7832901948193	20	0.0118	0.156403002688315	Proximal tubule bicarbonate reclamation	1277
748	120	18.0055930991822	120	0.0119	0.156403002688315	Cell-Cell communication	249
163	59	14.7109085044073	59	0.0122	0.156500876907769	Colorectal cancer	311
247	102	15.413522100295	102	0.0123	0.156500876907769	Insulin resistance	808
257	56	15.399818263676	56	0.0123	0.156500876907769	Long-term depression	888
463	52	14.1303701675311	52	0.0128	0.158656107168818	Endothelins	475
724	15	9.38689561492249	15	0.0128	0.158656107168818	CRMPs in Sema3A signaling	338
1637	360	-3.96986061208989	360	0.0129	0.158656107168818	Signaling by PDGF	1550
1392	99	16.5758119150651	99	0.013	0.158656107168818	Potassium Channels	1236
524	46	13.1457221200717	46	0.0135	0.163094040236478	Regulation of Androgen receptor activity	1325
1703	16	9.95058068946233	16	0.0142	0.166114300240857	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1714
264	244	7.41270786961473	244	0.0147	0.166114300240857	MAPK signaling pathway	911
295	48	13.4053485835813	48	0.0148	0.166114300240857	Notch signaling pathway (KEGG)	1077
450	39	12.8947290034561	39	0.0148	0.166114300240857	Class I PI3K signaling events	297
1130	172	10.9044468272788	172	0.0149	0.166114300240857	Intra-Golgi and retrograde Golgi-to-ER traffic	835
577	31	11.9741000392089	31	0.015	0.166114300240857	a6b1 and a6b4 Integrin signaling	6
1067	11	9.30677711423535	11	0.015	0.166114300240857	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	727
1398	12	9.90418159090183	12	0.015	0.166114300240857	Presynaptic nicotinic acetylcholine receptors	1247
1705	22	10.6736986409829	22	0.015	0.166114300240857	TNFR1-induced NFkappaB signaling pathway	1717
1280	135	16.5954452734748	135	0.0153	0.167443214642784	Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell	1047
306	148	15.6378748337152	148	0.0154	0.167443214642784	Oxytocin signaling pathway	1126
1482	22	10.146930912762	22	0.0157	0.168912014771229	Recycling pathway of L1	1316
410	54	17.982307158015	54	0.016	0.168912014771229	Viral myocarditis	1846
139	141	14.0573154986778	141	0.0161	0.168912014771229	Breast cancer	196
1814	619	-35.6362693553409	619	0.0161	0.168912014771229	Vesicle-mediated transport	1840
459	31	11.5250651230323	31	0.0166	0.172643314476411	EPHA forward signaling	482
1697	43	13.2563945011244	43	0.0169	0.17424817287334	TBC/RABGAPs	1676
851	108	16.3950816906321	108	0.0174	0.177376286697864	Degradation of the extracellular matrix	391
750	14	8.30137758335812	14	0.0175	0.177376286697864	Cell-extracellular matrix interactions	251
1285	22	9.86514087785688	22	0.0179	0.179905974916316	Nitric oxide stimulates guanylate cyclase	1061
1236	194	11.6354192932645	194	0.0185	0.180816069805481	Muscle contraction	1005
735	135	14.6224198631761	135	0.0187	0.180816069805481	Cardiac conduction	220
1836	18	9.24543552072114	18	0.0188	0.180816069805481	cGMP effects	261
64	13	8.6763925068019	12	0.0189	0.180816069805481	Chinkungunya Virus (ssRNA)	268
1393	46	12.9809801039333	46	0.0189	0.180816069805481	Pre-NOTCH Expression and Processing	1241
1788	11	9.03348796843697	11	0.0189	0.180816069805481	Transport of organic anions	1782
116	135	11.2434150904292	135	0.0192	0.180816069805481	Apelin signaling pathway	116
1525	11	7.4780111611049	11	0.0192	0.180816069805481	Regulation of signaling by NODAL	1361
1189	581	-33.3990405412168	581	0.0195	0.181651607722032	Membrane Trafficking	926
359	144	17.5047658394375	144	0.0196	0.181651607722032	Ribosome	1415
900	13	8.23275840885704	13	0.0201	0.181651607722032	ERBB2 Activates PTK6 Signaling	500
551	21	9.44510601684199	21	0.0202	0.181651607722032	Signaling events mediated by the Hedgehog family	1572
862	30	11.2792438318784	30	0.0202	0.181651607722032	Disassembly of the destruction complex and recruitment of AXIN to the membrane	407
1276	40	11.410861495475	40	0.0202	0.181651607722032	Netrin-1 signaling	1042
474	55	12.0883155244471	55	0.022	0.193474302633469	Fc-epsilon receptor I signaling in mast cells	536
550	52	11.4114609013484	52	0.022	0.193474302633469	Signaling events mediated by focal adhesion kinase	1563
995	19	9.50972457490884	19	0.022	0.193474302633469	GABA synthesis, release, reuptake and degradation	610
107	34	16.2751335517665	34	0.0227	0.195487890986895	Allograft rejection	78
1154	25	10.879035487006	25	0.0231	0.195487890986895	Laminin interactions	869
711	11	7.02058647330627	11	0.0232	0.195487890986895	CD28 dependent Vav1 pathway	232
697	43	12.8277639925517	43	0.0233	0.195487890986895	Bile acid and bile salt metabolism	182
1529	12	7.76954816042738	12	0.0233	0.195487890986895	Repression of WNT target genes	1379
777	64	13.7118823125674	64	0.0234	0.195487890986895	Collagen biosynthesis and modifying enzymes	306
176	46	11.6626134357452	46	0.0235	0.195487890986895	Endocrine and other factor-regulated calcium reabsorption	468
1001	16	8.48734189973712	16	0.0236	0.195487890986895	GRB2 events in ERBB2 signaling	686
460	17	8.43898076606945	17	0.0237	0.195487890986895	EPHA2 forward signaling	484
325	120	11.3129121580919	120	0.0241	0.196374040338786	Platelet activation	1213
1779	635	-43.0656061146447	635	0.0242	0.196374040338786	Transmembrane transport of small molecules	1774
1377	37	11.1782016587277	37	0.0243	0.196374040338786	Platelet Aggregation (Plug Formation)	1216
1557	13	7.61679571864892	13	0.0246	0.197464193682286	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	1482
100	66	11.714097377888	66	0.025	0.199337160289028	Adipocytokine signaling pathway	62
1281	46	12.18776382733	46	0.0255	0.201682303351252	Neurotransmitter Release Cycle	1048
719	28	9.58644050376174	28	0.0258	0.201682303351252	COPI-independent Golgi-to-ER retrograde traffic	329
1243	15	7.89396668820465	15	0.0258	0.201682303351252	N-Glycan antennae elongation	1013
282	15	7.90177807705255	15	0.0263	0.204255869439017	N-glycan biosynthesis, complex type	1016
1601	348	-11.5212419527154	348	0.0268	0.206796228222424	Signaling by EGFR	1512
663	37	11.0280228737721	37	0.0271	0.207770655532026	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	101
1670	19	8.44702903754584	19	0.0276	0.20968250658251	Syndecan interactions	1637
779	39	13.2001141402799	39	0.0277	0.20968250658251	Collagen degradation	308
1564	14	7.80787063248854	14	0.0284	0.211718350369092	SHC1 events in ERBB4 signaling	1498
225	90	11.4366188982927	90	0.0285	0.211718350369092	GnRH signaling pathway	677
747	127	14.7363609931255	127	0.0285	0.211718350369092	Cell surface interactions at the vascular wall	248
1656	250	-5.90814634673778	290	0.029	0.214102875865993	Signalling to ERKs*	1578
1797	11	7.16833058039211	11	0.0293	0.214990630544854	Type I hemidesmosome assembly	1808
1539	123	10.2227413623164	123	0.0317	0.227314305592752	Response to elevated platelet cytosolic Ca2+*	1389
469	33	10.7007410557793	33	0.0319	0.227314305592752	FAS (CD95) signaling pathway	521
419	147	6.55663528488842	147	0.0321	0.227314305592752	mTOR signaling pathway (KEGG)	997
421	24	8.89771925111845	24	0.0322	0.227314305592752	ALK1 signaling events	76
1823	20	8.07960361115685	20	0.0323	0.227314305592752	VxPx cargo-targeting to cilium	1857
1306	105	10.4726109793589	105	0.0324	0.227314305592752	O-linked glycosylation	1101
1666	32	10.2014746461654	32	0.0324	0.227314305592752	Striated Muscle Contraction	1612
1274	19	8.36369064707005	19	0.0325	0.227314305592752	Nephrin interactions	1039
1424	82	10.2204468163854	82	0.033	0.228143108307674	RAB GEFs exchange GTP for GDP on RABs	1298
1820	43	11.3037538563915	43	0.033	0.228143108307674	Voltage gated Potassium channels	1854
791	54	10.7722902249266	54	0.0336	0.23031985034538	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants*	323
610	14	8.59687193600508	14	0.0337	0.23031985034538	Acetylcholine Binding And Downstream Events*	13
1425	56	10.2636918154053	56	0.034	0.23104989033501	RAB geranylgeranylation	1299
718	80	10.176020236906	80	0.0342	0.231095962097789	COPI-dependent Golgi-to-ER retrograde traffic	328
337	22	8.25563687155507	22	0.0344	0.231141516200311	Protein export	1269
1346	35	9.20499123085123	35	0.0348	0.232522899823179	PLC-gamma1 signalling	1223
1524	18	7.66492386834824	18	0.0351	0.233224477538163	Regulation of signaling by CBL	1360
1254	44	10.3596060401531	44	0.0354	0.233918303013202	NOTCH1 Intracellular Domain Regulates Transcription	1081
1596	12	7.49258683187881	12	0.0357	0.234604504032472	Signal regulatory protein (SIRP) family interactions	1503
508	29	8.70021126876016	29	0.0378	0.247047365866402	Noncanonical Wnt signaling pathway	1069
1211	25	9.27037411398479	25	0.0388	0.250841572515058	MicroRNA (miRNA) biogenesis	958
1824	25	9.26215968889692	25	0.0388	0.250841572515058	WNT ligand biogenesis and trafficking	1858
549	63	9.30077324389201	63	0.0396	0.251728392993265	Signaling events mediated by VEGFR1 and VEGFR2	1573
538	23	8.68274601509673	23	0.0397	0.251728392993265	S1P2 pathway	1464
709	31	9.00774914814015	31	0.0397	0.251728392993265	CD28 co-stimulation	230
766	180	1.1462758403401	180	0.0399	0.251728392993265	Cilium Assembly	284
1646	322	-13.4856235773617	322	0.0401	0.251728392993265	Signaling by VEGF*	1560
519	46	9.57095574025076	46	0.0402	0.251728392993265	Presenilin action in Notch and Wnt signaling	1245
1210	15	7.45997229861929	15	0.0407	0.252218313692128	Methylation	955
1334	10	6.29185199313902	10	0.0407	0.252218313692128	PI3K events in ERBB4 signaling	1199
92	16	7.02178223375927	16	0.0416	0.25646677942341	2-Oxocarboxylic acid metabolism	2
434	63	9.00570340729249	63	0.0422	0.258731497844535	BCR signaling pathway	174
106	36	9.30149999741031	36	0.0424	0.258731497844535	Aldosterone-regulated sodium reabsorption	75
513	21	7.55818692913825	21	0.043	0.260519853051007	PDGFR-alpha signaling pathway	1157
894	47	9.28534247470908	47	0.0434	0.260519853051007	EPH-ephrin mediated repulsion of cells	480
797	10	5.98039952400209	10	0.0435	0.260519853051007	Creatine metabolism	334
388	14	6.677055831852	14	0.0437	0.260519853051007	Thiamine metabolism	1702
1777	62	10.3579253175151	62	0.0438	0.260519853051007	Translocation of GLUT4 to the plasma membrane	1772
427	15	6.5747306959291	15	0.044	0.260519853051007	Arf6 downstream pathway	128
1807	13	6.1525324950086	13	0.0444	0.261483451437961	Uptake and function of anthrax toxins	1822
863	803	-80.9038777071667	803	0.0446	0.261483451437961	Disease	408
446	48	9.60813826549211	48	0.045	0.262428339176624	Caspase cascade in apoptosis	227
1692	19	6.93516432060531	19	0.0452	0.262428339176624	Synthesis, secretion, and deacylation of Ghrelin	1664
504	33	8.69041835045036	33	0.046	0.264956282910488	N-cadherin signaling events	1012
394	107	10.0396789021075	107	0.0463	0.264956282910488	Toxoplasmosis	1732
1546	128	5.70175959786204	128	0.0463	0.264956282910488	Rho GTPase cycle	1402
74	52	9.78306912260856	49	0.0471	0.26659016483514	Human Cytomegalovirus (dsDNA)	750
114	28	8.54148941331449	28	0.0473	0.26659016483514	Antifolate resistance	100
723	26	7.46815035270911	26	0.0474	0.26659016483514	CREB phosphorylation through the activation of Ras	337
1287	43	9.44073665764232	43	0.0475	0.26659016483514	Non-integrin membrane-ECM interactions	1067
484	27	8.22212586198185	27	0.0477	0.26659016483514	IGF1 pathway	763
814	14	6.15948552248415	14	0.0481	0.267575369578668	DCC mediated attractive signaling	366
953	355	-19.2316720725702	355	0.0485	0.268551452056052	Fc epsilon receptor (FCERI) signaling	533
1837	12	5.97720508636575	12	0.0494	0.272274351657456	eNOS activation	477
1209	11	10.8691327607812	11	0.0498	0.272367047194918	Metallothioneins bind metals*	952
228	94	6.90379291759378	94	0.05	0.272367047194918	HIF-1 signaling pathway	724
892	35	8.1674256225792	35	0.0501	0.272367047194918	EGFR interacts with phospholipase C-gamma	462
1213	17	6.88293789345861	17	0.0507	0.272693235275391	Miscellaneous transport and binding events	962
461	32	8.08857471633107	32	0.051	0.272693235275391	EPHB forward signaling	485
441	73	8.85495424670617	73	0.0512	0.272693235275391	CXCR4-mediated signaling events	343
561	55	8.42164155565716	55	0.0513	0.272693235275391	TCR signaling in naive CD4+ T cells	1680
1643	323	-15.8463238336612	323	0.0513	0.272693235275391	Signaling by SCF-KIT	1556
1394	18	6.78803897083916	18	0.0521	0.275400024083526	Pre-NOTCH Processing in Golgi	1242
1571	105	6.58159377269266	105	0.0524	0.275400024083526	SRP-dependent cotranslational protein targeting to membrane	1602
796	65	10.4300375382878	65	0.0525	0.275400024083526	Costimulation by the CD28 family	333
909	41	7.78632956078675	41	0.0528	0.27576424619897	Elastic fibre formation	466
885	40	8.17454723585332	40	0.0532	0.276645311148947	Dual Incision in GG-NER	447
122	68	8.19656720435341	68	0.0549	0.283539926273187	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	134
1148	41	7.84794719911189	41	0.055	0.283539926273187	Kinesins	864
1114	28	8.75473018505273	28	0.0559	0.28551867299271	Interaction between L1 and Ankyrins	816
1855	88	6.84737138094794	88	0.056	0.28551867299271	p75 NTR receptor-mediated signalling	1137
148	61	7.63140656328677	61	0.0561	0.28551867299271	Central carbon metabolism in cancer	257
1542	14	6.00332074563552	14	0.0564	0.285829216278844	Retrograde neurotrophin signalling	1397
927	252	-9.3026731417831	252	0.0569	0.286547167915478	FCERI mediated MAPK activation	538
498	33	7.60441599193819	33	0.0571	0.286547167915478	Internalization of ErbB1	833
1111	27	7.92678687802717	27	0.0574	0.286547167915478	Integrin alphaIIb beta3 signaling	813
211	35	7.99847642762126	35	0.0575	0.286547167915478	Glycine, serine and threonine metabolism	654
1012	420	-32.0715971493392	420	0.0579	0.287343275868915	Gastrin-CREB signalling pathway via PKC and MAPK	624
1322	21	6.71681770676471	21	0.0582	0.287638580053424	PCNA-Dependent Long Patch Base Excision Repair	1154
1089	10	5.19245528656282	10	0.0588	0.287913591998105	Import of palmitoyl-CoA into the mitochondrial matrix	780
135	70	7.79555284884606	70	0.0593	0.287913591998105	Bile secretion	185
495	43	7.64670793682418	43	0.0594	0.287913591998105	Insulin Pathway	804
488	36	7.63810654496821	36	0.0595	0.287913591998105	IL2 signaling events mediated by PI3K	771
534	25	6.94417610943945	25	0.0597	0.287913591998105	Retinoic acid receptors-mediated signaling	1392
1648	324	-9.13849058962384	324	0.0597	0.287913591998105	Signaling by Wnt	1561
1706	13	5.69821559189945	13	0.0602	0.288480738370282	TNFR1-induced proapoptotic signaling	1718
1233	21	6.63296490004253	21	0.0603	0.288480738370282	Mitotic Spindle Checkpoint*	984
1641	396	-20.5544364257425	396	0.0614	0.291886556137506	Signaling by Rho GTPases	1554
1584	14	5.89241902405972	14	0.0615	0.291886556137506	Sema3A PAK dependent Axon repulsion	1481
1741	28	7.18821567509013	28	0.0621	0.293355238252121	The role of Nef in HIV-1 replication and disease pathogenesis	1700
738	50	7.19751704436318	50	0.0623	0.293355238252121	Cargo trafficking to the periciliary membrane	224
483	40	6.99693171519082	40	0.0631	0.295957054452652	IFN-gamma pathway	762
1366	10	5.00824382532333	10	0.064	0.299005740433543	Phenylalanine and tyrosine catabolism	1177
99	66	6.28360189906768	66	0.0649	0.301305784590724	Adherens junction	60
153	93	5.55838927717312	93	0.0653	0.301305784590724	Choline metabolism in cancer	274
183	98	4.73206018688331	98	0.0653	0.301305784590724	Estrogen signaling pathway	508
1475	18	6.10209758539112	18	0.0655	0.301305784590724	Ras activation uopn Ca2+ infux through NMDA receptor	1306
407	43	6.84507450284912	43	0.0668	0.304690260213648	Vasopressin-regulated water reabsorption	1833
1426	24	6.40205446244816	24	0.0668	0.304690260213648	RAF activation	1301
510	58	6.81650512257336	58	0.067	0.304690260213648	Notch signaling pathway (PID)	1078
1636	11	5.0358754326738	11	0.0673	0.304895247442082	Signaling by NOTCH4	1549
1270	15	5.90809290884455	15	0.0682	0.307806664114228	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	1035
1184	62	6.88464042142239	62	0.0693	0.311595455820218	Macroautophagy	903
84	14	6.83216860573561	11	0.0696	0.311772277665536	Murine Gammaherpesvirus (dsDNA)	1003
559	15	5.54137003290194	15	0.07	0.312394057169373	Syndecan-3-mediated signaling events	1640
954	82	5.84876404376916	82	0.0705	0.313455831978658	Fcgamma receptor (FCGR) dependent phagocytosis	540
1647	33	6.67679031108179	33	0.0712	0.314493807563913	Signaling by WNT in cancer	1562
1125	258	-13.7116761310432	258	0.072	0.314493807563913	Interleukin-3, 5 and GM-CSF signaling	828
1518	122	2.07791777559545	122	0.0723	0.314493807563913	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)*	1346
539	28	6.9864697522885	28	0.0724	0.314493807563913	S1P3 pathway	1465
562	46	6.95968730341799	46	0.0725	0.314493807563913	TCR signaling in naive CD8+ T cells	1681
621	11	4.91098636407039	11	0.0725	0.314493807563913	Activation of Ca-permeable Kainate Receptor*	26
1082	52	6.02263797988272	52	0.0726	0.314493807563913	IRE1alpha activates chaperones*	847
1420	24	6.36984287122744	24	0.0729	0.314493807563913	Pyrimidine metabolism (REACTOME)	1292
810	33	6.56814245772808	33	0.0731	0.314493807563913	DAG and IP3 signaling	362
720	78	5.11494746187079	78	0.0741	0.316569713997471	COPI-mediated anterograde transport	330
852	13	5.23239062860969	13	0.0747	0.316569713997471	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	393
489	28	6.77357585226575	28	0.0748	0.316569713997471	IL2 signaling events mediated by STAT5	772
532	26	6.21219052445301	26	0.0748	0.316569713997471	Regulation of p38-alpha and p38-beta	1353
95	117	1.93972087407014	117	0.0754	0.316569713997471	AMPK signaling pathway	94
494	42	6.65160009032489	42	0.0755	0.316569713997471	IL6-mediated signaling events	777
1437	11	4.80209484160849	11	0.0755	0.316569713997471	RHO GTPases activate KTN1	1407
349	204	-7.69722001297601	204	0.0757	0.316569713997471	Rap1 signaling pathway	1304
222	26	6.97999104812685	26	0.0767	0.31839519117838	Glycosphingolipid biosynthesis - lacto and neolacto series	671
572	60	5.98929379259821	60	0.0771	0.31839519117838	Validated targets of C-MYC transcriptional repression	1826
10	15	5.40654703652032	15	0.0772	0.31839519117838	TCA cycle	1677
1768	83	4.46015786091274	83	0.0773	0.31839519117838	Transcriptional regulation of white adipocyte differentiation	1763
913	11	5.99770713200853	11	0.0776	0.31839519117838	Endosomal/Vacuolar pathway	474
365	107	3.68136231292075	107	0.0779	0.31839519117838	Serotonergic synapse	1489
94	93	4.49905385020178	93	0.078	0.31839519117838	AGE-RAGE signaling pathway in diabetic complications	70
570	22	5.95198215803934	22	0.0789	0.319206128248785	VEGFR3 signaling in lymphatic endothelium	1839
416	191	-6.39118262530947	191	0.0791	0.319206128248785	cAMP signaling pathway	214
825	31	6.24680542690791	31	0.0791	0.319206128248785	DNA strand elongation	428
154	111	2.55092170926161	111	0.0797	0.319206128248785	Cholinergic synapse	275
689	37	6.35471266938404	37	0.0797	0.319206128248785	Base Excision Repair*	170
194	138	1.35739659010992	138	0.0798	0.319206128248785	Fluid shear stress and atherosclerosis	558
478	64	5.17457378673446	64	0.081	0.322926199668226	HIF-1-alpha transcription factor network	725
126	119	1.40856997105554	119	0.0815	0.323559854217489	Autophagy - animal	157
1389	84	5.98712757396918	84	0.0817	0.323559854217489	Post-translational modification: synthesis of GPI-anchored proteins	1233
97	11	5.6694768522909	11	0.0829	0.326152314236062	Acylglycerol degradation	53
1745	18	5.48816487747629	18	0.0829	0.326152314236062	Tie2 Signaling	1710
19	13	4.79837455760594	13	0.0836	0.326576399616376	fatty acid beta-oxidation	523
1635	11	4.58285973807787	11	0.0838	0.326576399616376	Signaling by NOTCH3	1548
406	117	2.73808474642445	117	0.0839	0.326576399616376	Vascular smooth muscle contraction	1831
1172	276	-17.2489249841018	276	0.0841	0.326576399616376	MAPK family signaling cascades	910
982	47	6.44289899504633	47	0.0844	0.326680705405709	G-protein mediated events*	597
1387	34	5.85297441253851	34	0.0848	0.326989611012579	Post NMDA receptor activation events	1231
278	60	5.44163849720437	60	0.0851	0.326989611012579	Mitophagy - animal	977
1598	13	4.82890082484396	13	0.0853	0.326989611012579	Signaling by Activin	1508
417	154	-2.67149485636788	154	0.0856	0.327091263656374	cGMP-PKG signaling pathway	262
105	81	4.21049907137154	81	0.086	0.327573167863499	Aldosterone synthesis and secretion	74
414	30	6.33510367976245	30	0.0871	0.330509815293102	beta-Alanine metabolism	176
1708	27	7.31219549365999	27	0.0875	0.330509815293102	TNFs bind their physiological receptors	1720
288	114	0.89072531253624	114	0.0876	0.330509815293102	Neurotrophin signaling pathway	1050
521	14	4.90459707540659	14	0.088	0.330974907649707	RXR and RAR heterodimerization with other nuclear receptor	1461
1792	159	-4.23236732987845	159	0.0886	0.332186941723033	Transport to the Golgi and subsequent modification	1787
275	271	-14.060180640482	271	0.0892	0.3333914005834	MicroRNAs in cancer	959
1531	24	5.6305247810996	24	0.09	0.335333540673132	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	1382
1159	10	4.49808388283732	10	0.0905	0.336149310673734	Ligand-independent caspase activation via DCC	881
1739	34	5.91266612976657	34	0.091	0.336960029466902	The phototransduction cascade*	1698
412	138	-2.08917190775816	138	0.0915	0.33746247874161	Wnt signaling pathway	1860
1678	27	5.19620375037913	27	0.0917	0.33746247874161	Synthesis of PC	1656
480	34	5.77472060542715	34	0.0928	0.340462978064205	HIV-1 Nef: Negative effector of Fas and TNF-alpha	737
890	55	5.15068965634319	55	0.0946	0.346005419510864	ECM proteoglycans	457
173	45	9.88932695814913	45	0.0949	0.346044448379795	Drug metabolism - other enzymes	445
518	25	5.46208255718166	25	0.0953	0.346446772806281	Plasma membrane estrogen receptor signaling	1212
199	81	4.11976890672424	81	0.0966	0.348359699999079	GABAergic synapse	611
34	25	5.54105580692196	25	0.0967	0.348359699999079	mucin core 1 and core 2 O-glycosylation	1001
454	48	5.59834355522037	48	0.0967	0.348359699999079	Downstream signaling in naive CD8+ T cells	438
630	37	5.17765742817696	37	0.097	0.348391072937581	Activation of NMDA receptor upon glutamate binding and postsynaptic events	37
1654	221	-11.9654705239559	221	0.0977	0.3498546208426	Signaling by the B Cell Receptor (BCR)	1558
1497	21	6.29345049745675	21	0.0982	0.349907908150205	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	1344
1132	40	5.41131086621908	40	0.0983	0.349907908150205	Intraflagellar transport	837
1305	35	5.40289942065117	35	0.0991	0.351708829400167	O-glycosylation of TSR domain-containing proteins*	1100
1805	12	4.38931526169902	12	0.0996	0.352437535469596	Unwinding of DNA	1820
688	45	4.94210575369581	45	0.1001	0.353161942388172	BMAL1:CLOCK,NPAS2 activates circadian gene expression	193
400	45	5.5941122847145	45	0.1019	0.356708602622472	Type II diabetes mellitus	1809
178	244	-15.3834810651256	244	0.102	0.356708602622472	Endocytosis	470
1600	57	5.00410414160568	57	0.102	0.356708602622472	Signaling by BRAF and RAF fusions	1510
1517	78	3.47510539938534	78	0.1026	0.35776080429716	Regulation of insulin secretion	1343
1675	27	5.23059093643817	27	0.1035	0.359849931800833	Synthesis of IP3 and IP4 in the cytosol	1653
127	28	4.91468653643113	28	0.1047	0.362253640571358	Autophagy - other	158
648	763	-90.9042716010152	763	0.1049	0.362253640571358	Adaptive Immune System	54
1196	16	4.75661290472333	16	0.1051	0.362253640571358	Metabolism of folate and pterines	938
61	10	4.43353465210676	10	0.1069	0.367399007498226	triacylglycerol degradation	1790
545	23	4.81335732654196	23	0.1078	0.368660486784538	Signaling events mediated by PRL	1568
517	22	4.6180498195991	22	0.1079	0.368660486784538	Paxillin-independent events mediated by a4b1 and a4b7	1153
299	19	5.05581618128657	19	0.1082	0.368660486784538	One carbon pool by folate	1108
301	123	0.0166034471633908	123	0.1085	0.368660486784538	Osteoclast differentiation	1116
121	18	4.59033335831341	18	0.1091	0.369618395518978	Arginine biosynthesis	132
112	65	3.2105972626311	65	0.1094	0.369618395518978	Amphetamine addiction	93
569	29	4.75080101600018	29	0.1108	0.373293927211679	VEGFR1 specific signals	1836
1834	13	4.47790349315847	13	0.1116	0.374217828643436	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism*	79
1651	18	4.89608762865801	18	0.1117	0.374217828643436	Signaling by cytosolic FGFR1 fusion mutants	1511
124	27	7.66959989489053	27	0.1139	0.380461900362235	Asthma	142
1007	10	3.76246907009319	10	0.1142	0.380461900362235	Gap junction degradation	618
1246	262	-20.170163631	262	0.1146	0.380733976152044	NCAM signaling for neurite out-growth	1022
280	29	5.13430640354349	29	0.1156	0.382529658009193	Mucin type O-glycan biosynthesis	1002
471	41	4.8847669877137	41	0.1159	0.382529658009193	FOXA1 transcription factor network	576
1026	23	4.53154306663473	23	0.1161	0.382529658009193	Glutamate Neurotransmitter Release Cycle	645
1311	71	3.02397342844732	71	0.1165	0.382793063302282	Oncogenic MAPK signaling	1107
994	52	5.21367793287589	52	0.1192	0.390591608325241	GABA receptor activation	609
710	21	4.5051952338308	21	0.1201	0.392465458208398	CD28 dependent PI3K/Akt signaling	231
1685	34	4.97599497561664	34	0.1206	0.393025529114825	Synthesis of bile acids and bile salts	1646
522	10	3.62759951996777	10	0.1213	0.394232568636834	Ras signaling in the CD4+ TCR pathway	1307
505	22	4.2910161466227	22	0.1243	0.401799065252858	Nectin adhesion pathway	1024
671	35	4.30131345925652	35	0.1243	0.401799065252858	Apoptotic cleavage of cellular proteins	122
512	31	4.00733903508936	31	0.1247	0.402005561531674	Osteopontin-mediated events	1117
1337	86	0.655265035291838	86	0.126	0.402755238820194	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	1203
136	65	2.30062561093777	65	0.1262	0.402755238820194	Biosynthesis of amino acids	188
1483	13	3.80792121799745	13	0.1263	0.402755238820194	Reduction of cytosolic Ca++ levels	1317
1414	65	2.0677921168345	65	0.1267	0.402755238820194	Protein-protein interactions at synapses	1275
38	27	4.81854936276734	27	0.1269	0.402755238820194	purine nucleotides de novo biosynthesis	1283
277	22	4.25081869757121	22	0.1276	0.402755238820194	Mismatch repair	963
217	14	3.92400640092032	14	0.1281	0.402755238820194	Glycosaminoglycan biosynthesis - keratan sulfate	665
658	27	5.04516485118253	27	0.1281	0.402755238820194	Amino acid transport across the plasma membrane	89
655	39	4.65499489282208	39	0.1283	0.402755238820194	Amine ligand-binding receptors	86
1825	13	3.78744481955436	13	0.1283	0.402755238820194	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	1861
1038	14	3.88513685114117	14	0.1302	0.407395321340702	Golgi Cisternae Pericentriolar Stack Reorganization	679
360	85	3.97779993636919	85	0.1307	0.407395321340702	Ribosome biogenesis in eukaryotes	1416
507	55	2.57527847227678	55	0.1308	0.407395321340702	Neurotrophic factor-mediated Trk receptor signaling	1049
931	31	4.63241406473047	31	0.1314	0.408201083563298	FGFR1 mutant receptor activation	546
104	170	0.798167823007353	170	0.1318	0.408382969835657	Alcoholism	73
42	14	4.23731339101834	14	0.1328	0.410418215292759	pyrimidine deoxyribonucleotides de novo biosynthesis	1290
497	45	3.22622275638157	45	0.1338	0.411690166005669	Integrins in angiogenesis	815
1436	13	3.70873414810644	13	0.1339	0.411690166005669	RHO GTPases activate IQGAPs	1406
231	90	2.42042204867659	90	0.1351	0.412400828830871	Hematopoietic cell lineage	707
297	25	4.46841842153988	25	0.1352	0.412400828830871	O-glycan biosynthesis, mucin type core	1099
447	22	3.97738482153063	22	0.1356	0.412400828830871	Cellular roles of Anthrax toxin	255
691	24	4.02659807628097	24	0.1358	0.412400828830871	Basigin interactions	172
187	12	3.61759634590014	12	0.1361	0.412400828830871	Fatty acid biosynthesis	525
1335	88	0.0800078916101236	88	0.1362	0.412400828830871	PI3K/AKT Signaling in Cancer	1202
158	28	3.88621723981278	28	0.1367	0.412869542598639	Citrate cycle (TCA cycle)	290
436	77	0.448997992677202	77	0.1381	0.415001937224846	C-MYB transcription factor network	201
1642	30	4.03814027978144	30	0.1381	0.415001937224846	Signaling by Robo receptor	1555
226	37	7.03958248869392	37	0.1391	0.416959383401562	Graft-versus-host disease	684
1244	26	3.77281233725729	26	0.1404	0.41920307290633	N-glycan antennae elongation in the medial/trans-Golgi	1014
1583	87	0.00836056203693865	87	0.1406	0.41920307290633	Selenocysteine synthesis	1480
170	126	-5.73041069343553	126	0.1409	0.41920307290633	Dopaminergic synapse	430
1316	10	3.97091243026043	10	0.1425	0.422911345030072	Organic cation transport	1114
1138	53	2.86093469191694	53	0.143	0.423344761207887	Ion transport by P-type ATPases	843
1	14	3.44217620510107	14	0.1437	0.424366665681976	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	1
624	40	3.62007628454175	40	0.1452	0.427740231634979	Activation of GABAB receptors*	29
1350	27	3.6168470232799	27	0.1463	0.429921767326067	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	1278
1665	97	-1.18433509715323	97	0.1467	0.430040609035301	Stimuli-sensing channels	1610
237	21	4.26681635024108	21	0.1471	0.430158869611483	Histidine metabolism	730
893	93	-1.81764103524339	93	0.1478	0.431151692059293	EPH-Ephrin signaling	481
1429	257	-23.6911601993831	257	0.1487	0.432653342574056	RET signaling	1391
290	35	4.52882105716199	35	0.1491	0.432653342574056	Nicotine addiction	1059
1268	38	2.87088853487397	38	0.1494	0.432653342574056	Negative regulation of MAPK pathway	1033
1279	10	3.15135790733695	10	0.1501	0.433162050960592	Neurotoxicity of clostridium toxins	1046
1597	20	3.70471005034412	20	0.1503	0.433162050960592	Signal transduction by L1	1505
746	79	0.889333927455441	79	0.1508	0.433558323628637	Cell junction organization	247
82	11	3.57210763144911	10	0.1514	0.434239511766315	JC Virus (dsDNA)	855
591	13	3.31313027002713	13	0.1518	0.434345180840304	AMER1 mutants destabilize the destruction complex*	85
590	13	3.31923057245708	13	0.156	0.445297331815109	AKT phosphorylates targets in the cytosol	71
1693	19	3.82746267620203	19	0.1566	0.445945704303741	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	1665
1200	92	-2.18128402873084	92	0.1571	0.44630690567325	Metabolism of nucleotides	942
1325	11	3.16517179628812	11	0.1584	0.44893373729548	PECAM1 interactions	1159
1373	19	3.35036324660309	19	0.159	0.449072772424717	Phosphorylation of the APC/C	1188
1704	37	3.02057207854151	37	0.1592	0.449072772424717	TNF signaling	1715
656	17	3.23430056916811	17	0.1598	0.449704633612048	Amine-derived hormones	87
1804	83	-1.33091688221242	83	0.1603	0.449839081158098	Unfolded Protein Response (UPR)	1819
1502	28	3.19689308518797	28	0.1606	0.449839081158098	Regulation of TNFR1 signaling	1364
1582	111	-4.04532799324898	111	0.1614	0.450474861551124	Selenoamino acid metabolism	1478
1029	119	-4.4855135707471	119	0.163	0.450474861551124	Glycerophospholipid biosynthesis	652
793	19	3.18384430184192	19	0.1632	0.450474861551124	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	325
1395	29	3.18012878322072	29	0.1638	0.450474861551124	Pre-NOTCH Transcription and Translation	1243
1009	29	3.94126229783705	29	0.164	0.450474861551124	Gap junction trafficking and regulation	620
367	136	-7.32882999511393	136	0.1641	0.450474861551124	Signaling pathways regulating pluripotency of stem cells	1576
142	172	-12.0031105165046	172	0.1645	0.450474861551124	Calcium signaling pathway	210
1826	15	3.19382879409308	15	0.1646	0.450474861551124	WNT5A-dependent internalization of FZD4	1862
905	14	3.17076559791075	14	0.1651	0.450474861551124	Early Phase of HIV Life Cycle	455
1381	87	-1.81858857253198	87	0.1652	0.450474861551124	Platelet homeostasis	1219
395	169	-12.1467127310127	169	0.1657	0.450474861551124	Transcriptional misregulation in cancer	1758
732	27	3.03753228804119	27	0.1658	0.450474861551124	Calmodulin induced events*	211
401	32	3.70171420661985	32	0.166	0.450474861551124	Tyrosine metabolism	1810
830	44	2.57473516972325	44	0.1661	0.450474861551124	Death Receptor Signalling	370
70	95	-3.19697353959904	91	0.167	0.450769998603172	Hepatitis B virus (dsDNART)	715
1057	23	3.46522058672746	23	0.1671	0.450769998603172	HSF1-dependent transactivation	748
389	29	2.69473779005917	29	0.1676	0.450769998603172	Thyroid cancer	1706
1698	227	-14.462047404032	227	0.1679	0.450769998603172	TCF dependent signaling in response to WNT	1678
1113	10	3.01482816200792	10	0.1693	0.450769998603172	Interaction With The Zona Pellucida	817
770	88	-1.43741522831153	88	0.1695	0.450769998603172	Class B/2 (Secretin family receptors)	294
694	16	3.23294699957034	16	0.1697	0.450769998603172	Beta-catenin phosphorylation cascade	178
168	34	2.68694795350088	34	0.17	0.450769998603172	DNA replication	425
330	34	3.20703589296761	34	0.1701	0.450769998603172	Prion diseases	1251
516	19	2.91166046437284	19	0.1711	0.450769998603172	Paxillin-dependent events mediated by a4b1	1152
974	183	-14.5199728693541	183	0.1711	0.450769998603172	G alpha (q) signalling events	589
1247	36	2.70604618940265	36	0.1719	0.450769998603172	NCAM1 interactions	1023
1072	20	3.4679968641796	20	0.1727	0.450769998603172	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	742
1088	112	1.58630229085786	112	0.173	0.450769998603172	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	779
1382	16	2.82501632473141	16	0.1731	0.450769998603172	Platelet sensitization by LDL	1220
886	65	0.00367579223679938	65	0.1735	0.450769998603172	Dual incision in TC-NER	448
628	31	3.70433995521386	31	0.1738	0.450769998603172	Activation of Matrix Metalloproteinases	34
351	199	-17.807189131952	199	0.174	0.450769998603172	Regulation of actin cytoskeleton	1322
552	38	2.09479517602546	38	0.1745	0.450769998603172	Signaling events regulated by Ret tyrosine kinase	1574
499	13	2.85421645931147	13	0.1746	0.450769998603172	JNK signaling in the CD4+ TCR pathway	857
926	29	2.77803386351964	29	0.175	0.450769998603172	FCERI mediated Ca+2 mobilization	537
387	102	-2.00646902161525	102	0.1768	0.450769998603172	Th17 cell differentiation	1694
1126	104	-4.41435072729506	104	0.1768	0.450769998603172	Interleukin-4 and 13 signaling	829
898	128	-7.75555949675978	128	0.1769	0.450769998603172	ER to Golgi Anterograde Transport	495
430	14	2.91199406588115	14	0.1775	0.450769998603172	Atypical NF-kappaB pathway	149
491	37	2.76926579515879	37	0.1776	0.450769998603172	IL23-mediated signaling events	774
948	151	-8.50565071677596	151	0.1776	0.450769998603172	Factors involved in megakaryocyte development and platelet production	518
1554	19	2.97536542161064	19	0.1776	0.450769998603172	SALM protein interactions at the synapses	1471
145	69	-0.330609241788342	69	0.1779	0.450769998603172	Cardiac muscle contraction	221
1181	31	2.43809858629387	31	0.1786	0.450769998603172	MET promotes cell motility	930
1217	14	2.8440556537359	14	0.1786	0.450769998603172	Misspliced GSK3beta mutants stabilize beta-catenin*	967
324	27	2.83361742480495	27	0.1791	0.450769998603172	Phototransduction	1190
1290	89	-2.6192802680025	89	0.1791	0.450769998603172	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1073
1604	50	1.32968474151654	50	0.1791	0.450769998603172	Signaling by ERBB2	1515
1623	500	-64.9677135991481	500	0.1794	0.450769998603172	Signaling by Interleukins	1535
1136	190	-14.9176219106537	190	0.1798	0.450827942389526	Ion channel transport	841
1005	10	3.19919159062989	10	0.1806	0.451000325153927	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	614
118	31	2.40472001305315	31	0.1808	0.451000325153927	Apoptosis - multiple species	117
786	24	2.82588333598294	24	0.181	0.451000325153927	Constitutive Signaling by AKT1 E17K in Cancer	319
486	28	3.04426593907257	28	0.1818	0.451804736922809	IL12 signaling mediated by STAT4	769
1112	66	0.368821794930833	66	0.1829	0.451804736922809	Integrin cell surface interactions	814
998	422	-49.0917428803635	422	0.184	0.451804736922809	GPCR ligand binding	682
1272	93	-3.98272306552366	93	0.1844	0.451804736922809	Negative regulation of the PI3K/AKT network	1036
1319	34	1.99048491743939	34	0.1851	0.451804736922809	Ovarian tumor domain proteases	1122
1818	93	-3.24741442433435	93	0.1853	0.451804736922809	Visual phototransduction	1847
739	27	2.76527523534802	27	0.1855	0.451804736922809	Caspase activation via extrinsic apoptotic signalling pathway	226
1838	22	2.54324344480321	22	0.1863	0.451804736922809	eNOS activation and regulation*	478
1197	758	-110.22138325994	757	0.1865	0.451804736922809	Metabolism of lipids and lipoproteins	939
1595	10	2.5707975379005	10	0.1866	0.451804736922809	Signal attenuation	1502
908	11	3.58111490829431	11	0.1868	0.451804736922809	Eicosanoids	465
133	32	2.34089021916699	32	0.187	0.451804736922809	Base excision repair	169
266	19	2.61840176145629	19	0.1872	0.451804736922809	Mannose type O-glycan biosynthesis	906
159	21	2.39699596185593	21	0.1881	0.451804736922809	Citrate cycle (TCA cycle, Krebs cycle)	289
29	18	2.91585741368838	18	0.1883	0.451804736922809	heparan sulfate biosynthesis (late stages)	711
768	18	2.57795154860019	18	0.1884	0.451804736922809	Citric acid cycle (TCA cycle)	292
574	21	2.8888332839252	21	0.1885	0.451804736922809	Visual signal transduction: Cones	1848
1110	107	-5.6105023393664	107	0.1886	0.451804736922809	Integration of energy metabolism	812
1819	16	3.00131511837941	16	0.189	0.451804736922809	Vitamin B5 (pantothenate) metabolism	1850
1160	111	-4.92083605313715	111	0.1892	0.451804736922809	Lipid digestion, mobilization, and transport	883
702	21	2.5584238021689	21	0.1894	0.451804736922809	Branched-chain amino acid catabolism	195
540	14	2.6548032984747	14	0.19	0.451804736922809	S1P4 pathway	1466
1638	67	-1.34763552146287	67	0.1908	0.451804736922809	Signaling by PTK6	1551
903	20	2.53780667952431	20	0.1913	0.451804736922809	ERK/MAPK targets	505
880	191	-17.3351733092978	191	0.1915	0.451804736922809	Downstream signaling events of B Cell Receptor (BCR)	437
220	15	2.91320154399221	15	0.1916	0.451804736922809	Glycosphingolipid biosynthesis - ganglio series	669
328	17	2.66924325283586	17	0.1918	0.451804736922809	Primary bile acid biosynthesis	1249
1300	25	2.56607617653673	25	0.1919	0.451804736922809	Nuclear signaling by ERBB4	1093
1158	20	4.21859989415177	20	0.1929	0.452897148914994	Ligand-gated ion channel transport	880
438	28	2.18238694857599	28	0.1933	0.452897148914994	CD40/CD40L signaling	233
182	81	-3.09789406228754	81	0.1935	0.452897148914994	ErbB signaling pathway	498
623	25	2.61315408708648	25	0.1949	0.454903531110453	Activation of G protein gated Potassium channels*	28
1756	142	-10.6763870590547	142	0.1962	0.454903531110453	Toll-Like Receptors Cascades	1731
273	10	2.52312385763656	10	0.1963	0.454903531110453	Methionine degradation	953
1806	31	1.80056764692511	31	0.1965	0.454903531110453	Uptake and actions of bacterial toxins	1821
1605	43	1.0941627730252	43	0.1968	0.454903531110453	Signaling by ERBB4	1516
1652	32	1.91691614713565	32	0.1968	0.454903531110453	Signaling by high-kinase activity BRAF mutants	1532
300	113	-7.05969207470724	113	0.1973	0.454903531110453	Oocyte meiosis	1109
555	39	1.01343039612016	39	0.1974	0.454903531110453	Stabilization and expansion of the E-cadherin adherens junction	1603
487	60	-0.143304579988911	60	0.1989	0.457182059609455	IL12-mediated signaling events	770
192	86	-3.79372019785424	86	0.1992	0.457182059609455	Fc gamma R-mediated phagocytosis	535
613	30	1.62375126107252	30	0.2002	0.457182059609455	Activated NOTCH1 Transmits Signal to the Nucleus	16
1691	22	2.35875519532179	22	0.2002	0.457182059609455	Synthesis of very long-chain fatty acyl-CoAs	1663
1025	29	2.14944008958367	29	0.2003	0.457182059609455	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity*	644
281	47	0.496705445404062	47	0.2009	0.457302897133653	N-Glycan biosynthesis	1015
944	24	2.3798982979781	24	0.2012	0.457302897133653	FRS-mediated FGFR2 signaling	582
1709	78	-2.95917019932145	78	0.2015	0.457302897133653	TP53 Regulates Metabolic Genes	1733
259	87	-4.40503131539329	87	0.2025	0.458060967953389	Longevity regulating pathway	890
258	64	-1.60180781858734	64	0.2026	0.458060967953389	Long-term potentiation	889
180	64	-1.38020369679283	64	0.2033	0.458776354944447	Epithelial cell signaling in Helicobacter pylori infection	490
1352	36	1.25225563626016	36	0.2038	0.459038567987616	Paradoxical activation of RAF signaling by kinase inactive BRAF*	1145
409	194	-17.4229097299503	194	0.2048	0.460423876998417	Viral carcinogenesis	1843
896	41	0.527876718350576	41	0.2059	0.4620283824035	EPHB-mediated forward signaling	486
557	16	2.47799697602348	16	0.2071	0.463850852762447	Syndecan-1-mediated signaling events	1638
769	295	-32.5666520953685	295	0.2076	0.463905174896519	Class A/1 (Rhodopsin-like receptors)	293
1430	278	-27.2477569743108	278	0.2079	0.463905174896519	RHO GTPase Effectors	1403
605	70	-2.24877580187199	70	0.2092	0.465936691982846	AURKA Activation by TPX2*	151
960	41	0.632499710767799	41	0.2107	0.468405275162434	Formation of Incision Complex in GG-NER	566
919	88	-4.42224587532111	90	0.212	0.469611817899826	Eukaryotic Translation Elongation*	511
1120	90	-2.02713385026088	90	0.2131	0.469611817899826	Interferon gamma signaling	822
279	85	-3.60344694903229	85	0.2135	0.469611817899826	Morphine addiction	987
1448	31	1.49637249465741	32	0.2135	0.469611817899826	RNA Polymerase I Promoter Escape*	1428
53	27	1.95063792531146	27	0.2143	0.469611817899826	superpathway of purine nucleotide salvage	1628
350	217	-23.1708996553905	217	0.2147	0.469611817899826	Ras signaling pathway	1308
1307	63	-1.08583796837432	63	0.2154	0.469611817899826	O-linked glycosylation of mucins	1102
917	13	2.59281116869969	13	0.2155	0.469611817899826	Erythrocytes take up carbon dioxide and release oxygen*	507
1106	44	0.168352860135968	44	0.2156	0.469611817899826	Inositol phosphate metabolism (REACTOME)	802
1151	23	1.92188873649426	23	0.216	0.469611817899826	LDL-mediated lipid transport	871
161	47	-0.278365338098006	47	0.2164	0.469611817899826	Cocaine addiction	305
653	13	2.26738672488586	13	0.2171	0.469611817899826	Advanced glycosylation endproduct receptor signaling	67
1644	72	-3.07930932451804	72	0.2176	0.469611817899826	Signaling by TGF-beta Receptor Complex	1557
1850	13	2.33349539450845	13	0.218	0.469611817899826	p38MAPK events	1130
1117	52	-0.894704358992993	52	0.2185	0.469611817899826	Interactions of neurexins and neuroligins at synapses	818
1002	15	2.4329118446168	15	0.2186	0.469611817899826	GRB2:SOS provides linkage to MAPK signaling for Integrins	687
1358	83	-3.54757339356376	83	0.2191	0.469611817899826	Peptide hormone metabolism	1165
428	34	1.15748369118572	34	0.2201	0.469611817899826	Arf6 signaling events	129
188	42	0.87749221794142	42	0.2212	0.469611817899826	Fatty acid degradation	526
564	41	0.394406584905945	41	0.2212	0.469611817899826	TNF receptor signaling pathway	1713
1786	101	-6.74765921787142	101	0.2213	0.469611817899826	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	1776
1735	12	2.08322224151265	12	0.2214	0.469611817899826	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1687
156	93	-5.78727671012829	93	0.2217	0.469611817899826	Circadian entrainment	286
287	256	-28.408823063382	256	0.2222	0.469611817899826	Neuroactive ligand-receptor interaction	1043
728	29	1.48438283735505	29	0.2227	0.469611817899826	Ca-dependent events	205
1131	43	0.0716923643012618	43	0.2227	0.469611817899826	Intra-Golgi traffic	836
1528	10	2.16516844775747	10	0.2228	0.469611817899826	Removal of the Flap Intermediate from the C-strand	1375
93	42	1.01940108020874	42	0.2235	0.469611817899826	ABC transporters	9
740	12	2.06485081785098	12	0.2235	0.469611817899826	Caspase-mediated cleavage of cytoskeletal proteins	228
129	68	-2.59576875279111	68	0.2239	0.469611817899826	B cell receptor signaling pathway	163
915	17	2.03068736575906	17	0.2239	0.469611817899826	Ephrin signaling	488
1135	31	1.73637697489856	31	0.2239	0.469611817899826	Inwardly rectifying K+ channels	840
1193	329	-42.7574458345828	329	0.2242	0.469611817899826	Metabolism of amino acids and derivatives	934
448	43	-0.18371946442948	43	0.2253	0.470894904305809	Ceramide signaling pathway	260
1839	56	-1.21412719503566	56	0.2256	0.470894904305809	mRNA 3'-end processing	988
1153	19	1.85749016520889	19	0.2263	0.470921040933245	Lagging Strand Synthesis	868
1383	17	1.95717105658731	17	0.2264	0.470921040933245	Polo-like kinase mediated events	1225
638	10	2.02810637791141	10	0.2275	0.471776128406754	Activation of the AP-1 family of transcription factors	42
311	18	2.18519368815085	18	0.2276	0.471776128406754	Pantothenate and CoA biosynthesis	1144
1750	118	-10.0339630230222	118	0.2286	0.472723506777105	Toll Like Receptor 4 (TLR4) Cascade	1724
1731	23	1.54613348345207	23	0.2292	0.472723506777105	Telomere C-strand (Lagging Strand) Synthesis	1682
1312	83	-4.5806689255006	83	0.2296	0.472723506777105	Opioid Signalling	1110
546	50	-0.764909977868934	50	0.231	0.472723506777105	Signaling events mediated by PTP1B	1569
1137	53	-1.23104479614477	53	0.2311	0.472723506777105	Ion homeostasis	842
525	25	1.39372124542243	25	0.2315	0.472723506777105	Regulation of CDC42 activity	1329
451	33	0.727116211081319	33	0.2319	0.472723506777105	Class I PI3K signaling events mediated by Akt	298
813	26	1.27084482815479	26	0.2319	0.472723506777105	DARPP-32 events	365
13	12	1.95418341176803	12	0.2325	0.472723506777105	bile acid biosynthesis, neutral pathway	184
1645	284	-36.8426774069504	287	0.2325	0.472723506777105	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)*	1559
943	23	1.6688949875437	23	0.2328	0.472723506777105	FRS-mediated FGFR1 signaling	581
1728	12	2.15556090557337	12	0.2328	0.472723506777105	Tandem pore domain potassium channels	1671
1405	11	1.97923032634253	11	0.2357	0.477599693687418	Processive synthesis on the C-strand of the telomere	1257
1559	22	1.53468948573598	22	0.236	0.477599693687418	SHC-mediated cascade:FGFR2	1493
1418	12	1.98286571072865	12	0.2364	0.477601061070875	Purine salvage	1286
826	11	2.19738303155923	11	0.2371	0.477603782025834	DSCAM interactions	446
286	122	-7.02442913479069	122	0.2372	0.477603782025834	Natural killer cell mediated cytotoxicity	1021
1173	29	0.772925382636511	29	0.2386	0.477812168240223	MAPK targets/ Nuclear events mediated by MAP kinases	912
386	88	-4.3694356053671	88	0.239	0.477812168240223	Th1 and Th2 cell differentiation	1693
439	69	-4.00715204947953	69	0.2393	0.477812168240223	CDC42 signaling events	235
1688	24	1.83252535395155	24	0.2394	0.477812168240223	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	1649
1419	12	1.93583943758309	12	0.2398	0.477812168240223	Pyrimidine catabolism	1287
787	64	-2.74587544437281	64	0.24	0.477812168240223	Constitutive Signaling by Aberrant PI3K in Cancer	318
323	138	-13.4394262205184	138	0.2401	0.477812168240223	Phospholipase D signaling pathway	1184
204	95	-6.76102229801556	95	0.2407	0.478210509783081	Glucagon signaling pathway	633
581	20	1.49485673729812	20	0.2413	0.478607530126791	p38 signaling mediated by MAPKAP kinases	1129
675	275	-35.8241466519065	275	0.2425	0.479595323168115	Asparagine N-linked glycosylation	136
1744	10	1.81280662237934	10	0.2426	0.479595323168115	Thyroxine biosynthesis	1709
67	17	2.83436894162895	13	0.2431	0.479783923730144	Enterovirus 71 (ssRNA)	479
338	155	-16.1036268780808	155	0.2439	0.479783923730144	Protein processing in endoplasmic reticulum	1272
1216	14	1.78419189767727	14	0.2439	0.479783923730144	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	966
1364	19	1.74617212077457	19	0.2443	0.479783923730144	Phase 4 - resting membrane potential	1175
377	63	-3.40021703652864	63	0.2459	0.481536042109967	Synaptic vesicle cycle	1636
429	43	-0.922460547148765	43	0.2461	0.481536042109967	Arf6 trafficking events	130
382	105	-8.55980306733793	105	0.2464	0.481536042109967	TNF signaling pathway	1716
284	85	-5.61793969206375	85	0.2474	0.48267377223956	NF-kappa B signaling pathway	1052
722	16	1.52337727452663	16	0.2481	0.48267377223956	CREB phosphorylation through the activation of CaMKII	336
951	230	-28.5472504878878	230	0.2484	0.48267377223956	Fatty acid, triacylglycerol, and ketone body metabolism	529
1431	109	-9.43741164585104	109	0.2488	0.48267377223956	RHO GTPases Activate Formins	1405
144	103	-8.62353084714453	103	0.249	0.48267377223956	Carbon metabolism	219
77	317	-41.4089626337585	298	0.2502	0.484140924126899	Human Immunodeficiency Virus type 1 (ssRNART)	753
249	132	-13.3885418151438	132	0.2519	0.484140924126899	Insulin signaling pathway	810
1068	41	-0.573616876477261	41	0.2521	0.484140924126899	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	731
690	10	1.78020030143473	10	0.2526	0.484140924126899	Base-Excision Repair, AP Site Formation	171
563	50	-1.64494076768251	50	0.253	0.484140924126899	TGF-beta receptor signaling	1689
1829	28	0.562028070518337	28	0.253	0.484140924126899	YAP1- and WWTR1 (TAZ)-stimulated gene expression	1865
921	87	-6.16949215948907	87	0.2532	0.484140924126899	Eukaryotic Translation Termination	513
476	80	-5.56720785299003	80	0.2533	0.484140924126899	Glucocorticoid receptor regulatory network	636
701	10	1.69898121508566	10	0.2534	0.484140924126899	Biotin transport and metabolism	191
1214	15	1.52692346435429	15	0.2576	0.490958869188812	Mismatch Repair	964
384	11	1.61608077446903	11	0.258	0.490958869188812	Taurine and hypotaurine metabolism	1675
201	85	-6.43664211549318	85	0.2582	0.490958869188812	Gap junction	616
14	11	1.50852238070766	11	0.2589	0.491298180160851	cholesterol biosynthesis I*	271
1008	27	1.28552474524638	27	0.2592	0.491298180160851	Gap junction trafficking	619
528	63	-3.74533586966861	63	0.2601	0.492224006878256	Regulation of Telomerase	1362
1639	47	-1.73146748374322	47	0.2609	0.49274636846209	Signaling by RAS mutants	1552
946	21	1.20014623840966	21	0.2612	0.49274636846209	FRS-mediated FGFR4 signaling	584
361	32	-0.0225461612001565	32	0.2622	0.493242122523652	SNARE interactions in vesicular transport	1590
686	92	-1.02586234409203	92	0.2625	0.493242122523652	B-WICH complex positively regulates rRNA expression	164
612	10	1.81159912633154	10	0.2627	0.493242122523652	Acetylcholine regulates insulin secretion	15
1017	82	-6.31776864099332	82	0.2636	0.493316634216716	Global Genome Nucleotide Excision Repair (GG-NER)	631
1292	16	1.34096791265284	16	0.2652	0.493316634216716	Norepinephrine Neurotransmitter Release Cycle	1076
422	11	1.50147567767087	11	0.2653	0.493316634216716	ALK2 signaling events	77
579	60	-3.71901180933337	60	0.2654	0.493316634216716	mTOR signaling pathway (PID)	998
1206	116	-11.1764703963098	116	0.2657	0.493316634216716	Metabolism of water-soluble vitamins and cofactors	948
1314	320	-45.2934263466141	320	0.2669	0.493316634216716	Organelle biogenesis and maintenance	1112
366	61	-3.7751440998781	61	0.2671	0.493316634216716	Shigellosis	1499
117	132	-13.5392248123084	132	0.2673	0.493316634216716	Apoptosis (KEGG)	118
1359	178	-18.9079333262939	178	0.2674	0.493316634216716	Peptide ligand-binding receptors	1166
1521	13	1.71660124999059	13	0.2695	0.493316634216716	Regulation of necroptotic cell death	1350
241	90	-6.68861458320395	90	0.2702	0.493316634216716	IL-17 signaling pathway	766
860	17	2.20036737112162	17	0.2703	0.493316634216716	Digestion of dietary lipid	403
511	46	-2.15411076480954	46	0.2711	0.493316634216716	Notch-mediated HES/HEY network	1080
1472	27	0.186543241216386	27	0.2713	0.493316634216716	RORA activates gene expression	1456
1333	16	1.33256495567002	16	0.2715	0.493316634216716	PI3K events in ERBB2 signaling	1198
1144	27	0.758858336938999	27	0.2719	0.493316634216716	Keratan sulfate biosynthesis	860
874	29	0.315117011175808	29	0.272	0.493316634216716	Downregulation of ERBB2 signaling	432
370	117	-12.3908418223711	117	0.2727	0.493316634216716	Sphingolipid signaling pathway	1597
1041	134	-7.98614853927752	134	0.2733	0.493316634216716	HATs acetylate histones	694
1056	11	1.42793359136128	11	0.2734	0.493316634216716	HSF1 activation	747
1707	96	-8.23990798893089	96	0.2734	0.493316634216716	TNFR2 non-canonical NF-kB pathway	1719
296	43	-1.37632426436601	43	0.274	0.493316634216716	Nucleotide excision repair	1095
346	69	-5.2548784832632	69	0.2741	0.493316634216716	RNA degradation	1422
1265	33	-0.54486944706138	33	0.2745	0.493316634216716	Negative regulation of FGFR2 signaling	1030
1092	22	0.975922570057022	22	0.2753	0.493316634216716	Incretin synthesis, secretion, and inactivation	783
1592	33	-0.395242389877055	33	0.2755	0.493316634216716	Sialic acid metabolism	1500
729	61	-3.80077328705907	61	0.2758	0.493316634216716	Ca2+ pathway	206
1262	21	0.681072232436559	21	0.2759	0.493316634216716	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	1026
1371	192	-23.9633631210903	191	0.2759	0.493316634216716	Phospholipid metabolism	1186
1558	21	0.823686175301581	21	0.2772	0.493316634216716	SHC-mediated cascade:FGFR1	1492
1477	29	-0.239064251884183	29	0.2775	0.493316634216716	Recognition of DNA damage by PCNA-containing replication complex	1311
208	51	-0.913292342012523	51	0.278	0.493316634216716	Glutathione metabolism	648
531	71	-5.69821302644506	71	0.2783	0.493316634216716	Regulation of nuclear SMAD2/3 signaling	1351
209	50	-2.55824765181828	50	0.2786	0.493316634216716	Glycerolipid metabolism	651
171	28	-0.325760013382502	28	0.2788	0.493316634216716	Dorso-ventral axis formation	431
923	28	-0.0275986096484168	28	0.2789	0.493316634216716	Extension of Telomeres	515
1032	30	-0.101329457939251	30	0.279	0.493316634216716	Glycolysis	658
379	124	-4.4552830215527	124	0.2794	0.493316634216716	Systemic lupus erythematosus	1667
529	71	-5.69678765859271	71	0.2798	0.493316634216716	Regulation of Wnt-mediated beta catenin signaling and target gene transcription	1372
1004	33	-0.0847892070998374	33	0.2799	0.493316634216716	Gamma carboxylation, hypusine formation and arylsulfatase activation	613
1474	16	1.04760506188332	16	0.28	0.493316634216716	Rap1 signalling	1305
765	25	0.682281766269556	25	0.2808	0.493316634216716	Chylomicron-mediated lipid transport	283
506	25	0.148000837306954	25	0.281	0.493316634216716	Nephrin/Neph1 signaling in the kidney podocyte	1040
1812	12	1.28426876780173	12	0.2815	0.493316634216716	VLDLR internalisation and degradation	1853
184	41	-0.560711320736445	41	0.2821	0.493316634216716	Ether lipid metabolism	510
693	145	-16.3395163130574	145	0.283	0.493316634216716	Beta-catenin independent WNT signaling	177
1591	11	1.28768496828099	11	0.2835	0.493316634216716	Serotonin receptors	1491
676	13	1.16292486581197	13	0.2842	0.493316634216716	Assembly Of The HIV Virion	138
1302	109	-11.2550909330105	109	0.2842	0.493316634216716	Nucleotide Excision Repair	1096
767	67	-5.13686830663361	67	0.2845	0.493316634216716	Circadian Clock	285
1541	40	-0.984742184221072	40	0.2851	0.493316634216716	Retinoid metabolism and transport	1393
660	93	-9.10740809037656	93	0.2852	0.493316634216716	Anchoring of the basal body to the plasma membrane	97
1249	12	1.41795453518582	12	0.2853	0.493316634216716	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1053
1510	59	-4.01004232791502	59	0.2853	0.493316634216716	Regulation of actin dynamics for phagocytic cup formation	1323
1215	14	1.04203256708044	14	0.2855	0.493316634216716	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	965
157	30	-0.606128375312874	30	0.286	0.493316634216716	Circadian rhythm	287
1640	39	-1.41059526385169	39	0.2864	0.493316634216716	Signaling by Retinoic Acid	1553
937	12	1.23495420320153	12	0.2869	0.493316634216716	FGFR2c ligand binding and activation	552
872	13	1.07864560408429	13	0.2874	0.493316634216716	Dissolution of Fibrin Clot	417
72	161	-18.585163418635	145	0.2875	0.493316634216716	Hepatitis C Virus (ssRNA)	718
828	22	0.351661239115129	22	0.2879	0.493316634216716	Deadenylation of mRNA	368
41	14	1.18476138676178	14	0.2888	0.49415083168645	pyrimidine deoxyribonucleotides biosynthesis from CTP	1289
1679	12	1.11413011278205	12	0.2902	0.495836947850366	Synthesis of PE	1657
165	43	-1.66804444422254	43	0.2924	0.498342900722571	Cysteine and methionine metabolism	349
472	44	-2.16031847048955	44	0.2925	0.498342900722571	FOXA2 and FOXA3 transcription factor networks	577
470	47	-2.94339821242472	47	0.2944	0.499766737581778	FGF signaling pathway	544
1170	36	-1.37874381666772	36	0.295	0.499766737581778	MAP2K and MAPK activation	908
229	247	-34.0547122517653	247	0.2953	0.499766737581778	HTLV-I infection	749
150	99	-10.0018552938285	99	0.2974	0.499766737581778	Chagas disease (American trypanosomiasis)	263
1484	15	1.14819729118248	15	0.2976	0.499766737581778	Regulated Necrosis*	1319
1289	108	-11.6331773031288	108	0.2987	0.499766737581778	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)*	1072
455	19	0.566256681105969	19	0.2989	0.499766737581778	E-cadherin signaling in keratinocytes	449
467	35	-1.34434172794376	35	0.2989	0.499766737581778	ErbB2/ErbB3 signaling events	502
1810	28	-0.343775045683726	28	0.2993	0.499766737581778	VEGFR2 mediated vascular permeability	1838
1152	15	0.915563611159988	15	0.2997	0.499766737581778	LGI-ADAM interactions	878
1446	90	-3.35693888892205	90	0.2998	0.499766737581778	RNA Polymerase I Chain Elongation	1426
904	13	1.02205264573008	13	0.3001	0.499766737581778	ERKs are inactivated	506
650	15	1.00692219745527	15	0.3014	0.499766737581778	Adenylate cyclase inhibitory pathway*	59
1263	108	-6.57083395823877	108	0.3014	0.499766737581778	Negative epigenetic regulation of rRNA expression*	1027
1044	45	-0.402600812151185	45	0.3018	0.499766737581778	HDMs demethylate histones	697
1054	28	-0.407273157774869	28	0.3022	0.499766737581778	HS-GAG biosynthesis	745
1146	32	-0.860649509032885	32	0.3023	0.499766737581778	Keratan sulfate/keratin metabolism	862
435	33	-1.44438906256755	33	0.3024	0.499766737581778	BMP receptor signaling	194
1634	32	-1.19634079325489	32	0.3025	0.499766737581778	Signaling by NOTCH2	1547
698	41	-1.90480495440426	41	0.3031	0.499766737581778	Binding and Uptake of Ligands by Scavenger Receptors	186
501	63	-5.24602196310105	63	0.3033	0.499766737581778	LPA receptor mediated events	894
155	69	-6.27985884131452	69	0.3037	0.499766737581778	Chronic myeloid leukemia	282
1129	27	0.152769737746718	27	0.3039	0.499766737581778	Interleukin-7 signaling	832
1523	12	0.886170662507712	12	0.3039	0.499766737581778	Regulation of pyruvate dehydrogenase (PDH) complex	1355
942	13	0.906001205598769	13	0.3041	0.499766737581778	FGFRL1 modulation of FGFR1 signaling	557
593	25	-0.375289524368688	25	0.3042	0.499766737581778	APC-Cdc20 mediated degradation of Nek2A	109
55	19	0.503264162277112	19	0.3064	0.501579070173375	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	1630
423	54	-4.08341411794724	54	0.3064	0.501579070173375	ATF-2 transcription factor network	144
1264	32	-1.25587275749578	32	0.3069	0.501579070173375	Negative regulation of FGFR1 signaling	1029
181	191	-25.6110587947778	191	0.3074	0.501579070173375	Epstein-Barr virus infection	493
1770	147	-18.6757299133666	147	0.3074	0.501579070173375	Translation	1765
1323	92	-9.48884022802947	92	0.3081	0.501841471290909	PCP/CE pathway	1155
659	97	-4.80671134974995	97	0.3084	0.501841471290909	Amyloid fiber formation	95
357	95	-9.63522630078058	95	0.3092	0.50210244825041	Retrograde endocannabinoid signaling	1396
614	65	0.595988709601256	65	0.3094	0.50210244825041	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	17
1561	19	0.354937426167543	19	0.3103	0.502329643928352	SHC-mediated cascade:FGFR4	1495
1579	20	0.272092862525675	20	0.3107	0.502329643928352	Scavenging by Class A Receptors	1474
1288	63	-2.82358478535445	63	0.3108	0.502329643928352	Nonhomologous End-Joining (NHEJ)	1071
932	11	0.917352341533347	11	0.3132	0.505327760786607	FGFR1c ligand binding and activation*	547
547	52	-4.0905639077222	52	0.3135	0.505327760786607	Signaling events mediated by Stem cell factor receptor (c-Kit)	1570
1255	21	-0.0965700756608656	21	0.3142	0.505774447613561	NOTCH2 Activation and Transmission of Signal to the Nucleus	1082
321	15	0.665244997995355	15	0.3149	0.506219933669476	Phenylalanine metabolism	1178
1663	16	0.418358125142585	16	0.3154	0.506343143799943	Spry regulation of FGF signaling	1601
533	53	-4.52243651897392	53	0.3162	0.506588574421274	Regulation of retinoblastoma protein	1358
907	14	0.899297717528084	14	0.3164	0.506588574421274	Eicosanoid ligand-binding receptors	464
967	90	-4.15945153437516	90	0.3176	0.507754575664599	Formation of the beta-catenin:TCF transactivating complex	570
1011	64	-5.75343369086935	64	0.3183	0.507754575664599	Gap-filling DNA repair synthesis and ligation in TC-NER	622
760	19	0.212677817645835	19	0.319	0.507754575664599	Chondroitin sulfate biosynthesis	277
895	34	-1.60257683817464	34	0.3191	0.507754575664599	EPHA-mediated growth cone collapse	483
418	78	-8.26760447402962	78	0.3195	0.507754575664599	mRNA surveillance pathway	996
309	61	-5.68429339573796	61	0.3201	0.507754575664599	Pancreatic cancer	1142
1192	15	0.854771684926272	15	0.3201	0.507754575664599	Metabolism of Angiotensinogen to Angiotensins	935
404	59	-4.89474023171751	59	0.3226	0.5103664119781	VEGF signaling pathway	1834
1185	159	-21.406686134734	159	0.3226	0.5103664119781	Major pathway of rRNA processing in the nucleolus and cytosol	904
1701	32	-1.47983347597832	32	0.3241	0.511544385480499	TGF-beta receptor signaling activates SMADs	1690
1714	12	1.04787522816088	12	0.3242	0.511544385480499	TP53 Regulates Transcription of Death Receptors and Ligands	1738
839	10	0.867009699167274	10	0.3247	0.511658307872312	Defective EXT1 causes exostoses 1, TRPS2 and CHDS*	379
1439	91	-4.90065187131164	91	0.3253	0.511910351422871	RHO GTPases activate PKNs	1410
235	150	-19.9593359267447	150	0.3266	0.511910351422871	Hippo signaling pathway	728
635	17	0.12011969197163	17	0.3267	0.511910351422871	Activation of SMO	41
1021	30	-1.20861098178187	30	0.3267	0.511910351422871	Gluconeogenesis	638
322	90	-10.4284834104704	90	0.327	0.511910351422871	Phosphatidylinositol signaling system	1179
353	59	-5.81415930363275	59	0.3281	0.51211528634254	Renal cell carcinoma	1376
224	28	-1.29755451720051	28	0.3287	0.51211528634254	Glyoxylate and dicarboxylate metabolism	674
1317	15	0.992667952666068	15	0.3287	0.51211528634254	Organic cation/anion/zwitterion transport	1115
1360	28	-1.20321689146838	28	0.3292	0.51211528634254	Peroxisomal lipid metabolism	1168
319	74	-7.39533236550647	74	0.3293	0.51211528634254	Pertussis	1170
221	14	0.472815232491732	14	0.3297	0.51211528634254	Glycosphingolipid biosynthesis - globo and isoglobo series	670
1205	164	-22.3978900519263	164	0.3302	0.512226695155153	Metabolism of vitamins and cofactors	947
331	86	-9.72128174060809	86	0.3311	0.512957516360342	Progesterone-mediated oocyte maturation	1259
186	38	-1.84213338340034	38	0.3325	0.514460070862369	Fat digestion and absorption	522
371	16	-0.0183396116141336	16	0.3348	0.516792463311581	Sphingosine biosynthesis	1599
649	10	0.780095511431487	10	0.3353	0.516792463311581	Adenylate cyclase activating pathway	58
130	74	-8.12190096397519	74	0.3354	0.516792463311581	Bacterial invasion of epithelial cells	165
1235	30	-1.79180426515737	30	0.3361	0.516792463311581	Molecules associated with elastic fibres	986
283	13	0.594090341510952	13	0.3364	0.516792463311581	N-glycan precursor biosynthesis	1017
864	56	-4.73275655011597	56	0.3366	0.516792463311581	Diseases associated with O-glycosylation of proteins	410
509	17	-0.010845232465777	17	0.3378	0.51746299568907	Nongenotropic Androgen signaling	1070
246	22	-0.530239304287528	22	0.3387	0.51746299568907	Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4	803
855	22	-0.632805746382937	22	0.3389	0.51746299568907	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models*	396
1119	68	-5.2415598426968	68	0.3389	0.51746299568907	Interferon alpha/beta signaling	821
26	14	0.527369341367424	14	0.3392	0.51746299568907	guanosine nucleotides de novo biosynthesis	692
1156	13	0.411380113965484	13	0.3399	0.517515787895409	Leading Strand Synthesis*	872
1267	30	-1.72462150662982	30	0.3401	0.517515787895409	Negative regulation of FGFR4 signaling	1032
198	30	-1.60422940488755	30	0.3425	0.520210484724427	Fructose and mannose metabolism	586
1128	11	0.544059424190837	11	0.343	0.520210484724427	Interleukin-6 signaling	831
805	722	-125.120244196074	722	0.3443	0.520210484724427	Cytokine Signaling in Immune system	351
977	45	-3.84664048832733	45	0.3457	0.520210484724427	G beta:gamma signalling through PI3Kgamma	592
674	57	-4.86285847513842	57	0.3458	0.520210484724427	Arachidonic acid metabolism (REACTOME)	126
755	77	-8.83727903690323	77	0.346	0.520210484724427	Centrosome maturation*	258
1687	15	0.492141986805574	15	0.3461	0.520210484724427	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	1648
332	70	-7.77505702529003	70	0.3463	0.520210484724427	Prolactin signaling pathway	1262
868	79	-8.86242724725289	79	0.3473	0.520210484724427	Diseases of glycosylation	412
543	38	-2.23542393447968	38	0.3477	0.520210484724427	Signaling events mediated by HDAC Class III	1566
1803	15	-0.00831048664222249	15	0.3478	0.520210484724427	Unblocking of NMDA receptor, glutamate binding and activation	1818
50	63	-6.87197287395386	63	0.348	0.520210484724427	superpathway of inositol phosphate compounds	1625
468	32	-2.01188642998786	32	0.3482	0.520210484724427	ErbB4 signaling events	503
535	40	-3.53173210235753	40	0.3488	0.520210484724427	RhoA signaling pathway	1413
354	62	-6.49704020237471	62	0.3491	0.520210484724427	Renin secretion	1377
721	66	-7.39439606693867	66	0.3492	0.520210484724427	COPII (Coat Protein 2) Mediated Vesicle Transport	331
496	29	-2.0275464680328	29	0.3496	0.520210484724427	Insulin-mediated glucose transport	811
662	24	-0.583613102965787	24	0.3497	0.520210484724427	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	102
96	52	-5.01947767725588	52	0.3515	0.522035828707297	Acute myeloid leukemia	47
682	15	0.421986219542072	15	0.3518	0.522035828707297	Attenuation phase	148
981	48	-4.55876770621397	48	0.353	0.523167416966743	G-protein beta:gamma signalling	596
935	32	-2.31554728123509	32	0.3538	0.523204605880992	FGFR2 mutant receptor activation	550
1732	78	-6.27539629622871	78	0.3539	0.523204605880992	Telomere Maintenance	1683
1485	10	0.463382311822507	10	0.3544	0.523278434795626	Regulated proteolysis of p75NTR	1320
955	26	-1.49912735321513	26	0.3549	0.523278434795626	Fertilization*	543
500	41	-3.80849353385556	41	0.3554	0.523278434795626	LKB1 signaling events	887
775	65	-7.10128378872515	65	0.3557	0.523278434795626	Cleavage of Growing Transcript in the Termination Region*	301
179	48	-4.88718136889264	48	0.3569	0.524117998737965	Endometrial cancer	472
615	107	-14.6508483522988	107	0.3572	0.524117998737965	Activated TLR4 signalling	20
218	10	0.412105325368237	10	0.358	0.524117998737965	Glycosaminoglycan biosynthesis, heparan sulfate backbone	666
1840	29	-2.02236404027376	29	0.3586	0.524117998737965	mRNA Capping	989
1766	37	-3.0314069735222	37	0.3587	0.524117998737965	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	1760
1608	49	-5.21936971362114	49	0.3589	0.524117998737965	Signaling by FGFR1	1519
866	22	-0.830543393214719	22	0.3599	0.524387682979313	Diseases associated with the TLR signaling cascade*	411
48	32	-2.54956501302752	32	0.3604	0.524387682979313	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	1622
857	34	-2.77934828802944	34	0.3604	0.524387682979313	Detoxification of Reactive Oxygen Species	399
833	16	-0.249356281847577	16	0.3613	0.525058439944782	Defective B3GALT6 causes EDSP2 and SEMDJL1*	373
327	39	-1.65121910548875	39	0.3627	0.526453310947796	Porphyrin and chlorophyll metabolism	1229
119	61	-5.84902044536019	61	0.3632	0.526540048123455	Arachidonic acid metabolism (KEGG)	125
262	11	0.318181550780449	11	0.3646	0.527929748000337	Lysine degradation, lysine => saccharopine => acetoacetyl-CoA	898
1034	116	-16.3904846575116	116	0.3651	0.528014490119886	Glycosaminoglycan metabolism	668
372	125	-18.0343384397576	125	0.3666	0.528656303204394	Spliceosome	1600
466	100	-14.321781728848	100	0.3672	0.528656303204394	ErbB1 downstream signaling	499
1849	15	-0.0308116244091924	15	0.368	0.528656303204394	p130Cas linkage to MAPK signaling for integrins	1127
934	19	-0.565034037559779	19	0.3681	0.528656303204394	FGFR2 ligand binding and activation	549
260	61	-7.32581342579883	61	0.3682	0.528656303204394	Longevity regulating pathway - multiple species	891
207	110	-15.2241903913398	110	0.3694	0.528656303204394	Glutamatergic synapse	646
1014	135	-16.0137971127511	135	0.3696	0.528656303204394	Gene Silencing by RNA	626
1368	17	-0.447360035074476	17	0.37	0.528656303204394	Phospholipase C-mediated cascade; FGFR2	1180
1372	20	0.104653367459079	20	0.3704	0.528656303204394	Phosphorylation of CD3 and TCR zeta chains	1187
1183	99	-12.646905486502	99	0.3711	0.528656303204394	MHC class II antigen presentation	957
1590	15	-0.385040147640016	15	0.3715	0.528656303204394	Serotonin Neurotransmitter Release Cycle	1490
1761	78	-9.914562555004	78	0.3716	0.528656303204394	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1755
1501	16	0.00331627986455425	16	0.3721	0.528656303204394	Regulation of TLR by endogenous ligand	1363
1586	24	-1.6600318613483	24	0.3721	0.528656303204394	Sema4D induced cell migration and growth-cone collapse	1484
1296	23	-1.54242234271041	23	0.3727	0.528656303204394	Nuclear Events (kinase and transcription factor activation)	1089
1832	17	-0.750620926732674	17	0.3729	0.528656303204394	Zinc transporters	1868
403	125	-18.6606094476025	125	0.3734	0.528656303204394	Ubiquitin mediated proteolysis	1814
1427	22	-1.3473787638962	22	0.3735	0.528656303204394	RAF-independent MAPK1/3 activation	1302
452	54	-6.33512596963714	54	0.375	0.530152022045288	Coregulation of Androgen receptor activity	332
206	27	0.10774050463945	27	0.3761	0.53107938123757	Glucuronate pathway (uronate pathway)	642
1400	10	0.149965106065477	10	0.3775	0.532427674592747	Processing and activation of SUMO	1252
1133	43	-4.43119833765618	43	0.3785	0.532595201504629	Intrinsic Pathway for Apoptosis	838
1386	106	-11.2085119104573	106	0.379	0.532595201504629	Positive epigenetic regulation of rRNA expression	1230
1543	45	-5.04878633325038	45	0.3791	0.532595201504629	Retrograde transport at the Trans-Golgi-Network	1398
616	16	-0.503419016654509	16	0.3794	0.532595201504629	Activated point mutants of FGFR2	18
1207	24	-1.90161776332459	24	0.3802	0.532888450749241	Metal ion SLC transporters	950
1742	32	-2.82829171311571	32	0.3805	0.532888450749241	Thrombin signalling through proteinase activated receptors (PARs)	1703
368	80	-10.9209485170199	80	0.3828	0.534856997373645	Small cell lung cancer	1588
1622	307	-52.9624875240489	307	0.3828	0.534856997373645	Signaling by Insulin receptor	1534
1811	22	-1.56528281836662	22	0.3835	0.534864814006295	VLDL interactions	1852
1585	27	-2.2865381930103	27	0.3837	0.534864814006295	Sema4D in semaphorin signaling	1483
824	63	-3.17596707883886	63	0.3864	0.538001481273671	DNA methylation	423
1759	14	-0.40121266164677	14	0.3872	0.538488477655198	Trafficking of GluR2-containing AMPA receptors	1751
1860	174	-27.9148935253503	174	0.3882	0.539252164628577	rRNA processing*	1459
1042	91	-8.05839133645153	91	0.389	0.539736580179341	HDACs deacetylate histones	695
234	171	-26.0473276964262	171	0.3899	0.540358462085925	Herpes simplex infection	719
987	17	-0.875213321673574	17	0.3907	0.540840475867523	G1/S-Specific Transcription	602
1315	10	0.0749655562585314	10	0.3917	0.541103936720056	Organic anion transporters	1113
149	12	-0.283270060525591	12	0.3918	0.541103936720056	Ceramide biosynthesis	259
603	12	0.00192630117234117	12	0.3927	0.541103936720056	ATF6 (ATF6-alpha) activates chaperones	147
1261	10	0.129423065882934	10	0.3927	0.541103936720056	Nef Mediated CD4 Down-regulation	1025
672	49	-5.97217268077295	49	0.3955	0.543846762829928	Apoptotic execution phase	123
83	79	-11.6159386032823	77	0.3956	0.543846762829928	Kaposi's Sarcoma-associated Virus (dsDNA)	859
1422	45	-5.54395560702276	45	0.3966	0.544595529992849	Pyruvate metabolism and Citric Acid (TCA) cycle	1296
705	12	0.419930997022886	12	0.3975	0.545205421203363	Butyrophilin (BTN) family interactions	200
1208	34	-3.04234116841672	34	0.3982	0.545539912213684	Metalloprotease DUBs	951
1015	28	-1.62300873049532	28	0.3988	0.545642858597311	Generation of second messenger molecules	627
449	12	-0.235138688551595	12	0.3999	0.545642858597311	Circadian rhythm pathway	288
1190	11	-0.293311760984093	11	0.4	0.545642858597311	Membrane binding and targetting of GAG proteins*	925
456	33	-3.41111491741433	33	0.4001	0.545642858597311	E-cadherin signaling in the nascent adherens junction	450
1449	62	-3.94846266335902	62	0.4014	0.546306278880852	RNA Polymerase I Promoter Opening	1429
1702	16	-0.94931287225684	16	0.4015	0.546306278880852	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1691
334	83	-12.3572389195031	83	0.4025	0.547044593293186	Prostate cancer	1266
46	19	-1.49238579073028	19	0.4038	0.548188503914027	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	1623
1253	28	-2.58134534155087	28	0.4063	0.550957062758042	NOD1/2 Signaling Pathway	1064
408	49	-6.69469360385498	49	0.408	0.552635751288269	Vibrio cholerae infection	1841
945	19	-1.59244370447309	19	0.4095	0.55354915833482	FRS-mediated FGFR3 signaling	583
1241	87	-13.4340870203615	87	0.4096	0.55354915833482	MyD88:Mal cascade initiated on plasma membrane*	1010
431	31	-3.55762521411413	31	0.4145	0.559130644428258	Aurora A signaling	152
254	13	-0.749614628446848	13	0.4151	0.559130644428258	Leucine degradation, leucine => acetoacetate + acetyl-CoA	876
108	147	-24.7117921470825	147	0.4155	0.559130644428258	Alzheimer's disease	83
1496	14	-0.788728891416298	14	0.4156	0.559130644428258	Regulation of IFNG signaling	1341
1134	20	-1.75906048857427	20	0.4165	0.559620620366976	Intrinsic Pathway of Fibrin Clot Formation	839
1188	76	-8.98778959138791	76	0.4169	0.559620620366976	Meiotic synapsis	921
1003	106	-17.0979772540465	107	0.4188	0.56081971539034	GTP hydrolysis and joining of the 60S ribosomal subunit*	689
634	12	-0.575697227929433	12	0.4191	0.56081971539034	Activation of Rac	40
383	79	-10.688508148076	79	0.4192	0.56081971539034	Taste transduction	1672
443	27	-3.07997654098352	27	0.4208	0.561945156522108	Calcium signaling in the CD4+ TCR pathway	209
1609	38	-4.8234490345483	38	0.4218	0.561945156522108	Signaling by FGFR1 in disease	1520
1232	136	-20.1128105816733	136	0.4227	0.561945156522108	Mitotic Prophase	983
1367	16	-1.15836334550888	16	0.4232	0.561945156522108	Phospholipase C-mediated cascade: FGFR1	1183
1019	42	-5.7977850253403	42	0.4233	0.561945156522108	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	634
1505	14	-0.86293650659325	14	0.4234	0.561945156522108	Regulation of TP53 Activity through Association with Co-factors	1367
1340	16	-1.21226431701627	16	0.4236	0.561945156522108	PKA activation	1207
1404	20	-1.75005644102571	20	0.4238	0.561945156522108	Processing of Intronless Pre-mRNAs	1256
8	15	-1.04719691618721	15	0.4252	0.563121971265116	D-myo-inositol-5-phosphate metabolism	361
7	12	-0.704991340181965	12	0.426	0.563121971265116	D-myo-inositol (1,4,5)-trisphosphate degradation	360
1450	109	-14.7450757695355	109	0.4261	0.563121971265116	RNA Polymerase I Transcription*	1430
12	10	-0.260476033412044	10	0.4269	0.563556514750902	adenosine deoxyribonucleotides de novo biosynthesis*	56
1565	67	-6.33690791074685	67	0.4291	0.565836221477544	SIRT1 negatively regulates rRNA Expression	1583
1778	17	-0.694255413169869	17	0.4298	0.56613509796624	Translocation of ZAP-70 to Immunological synapse	1773
637	41	-5.84002783059869	41	0.4315	0.567749073694493	Activation of gene expression by SREBF (SREBP)	30
1036	24	-2.85881124489817	24	0.4327	0.56847194558825	Glyoxylate metabolism and glycine degradation	675
881	31	-3.8435347663411	31	0.433	0.56847194558825	Downstream signaling of activated FGFR1	439
537	20	-2.11518982640414	20	0.4351	0.570602621327344	S1P1 pathway	1463
930	15	-1.21442232708891	15	0.4369	0.57144759060105	FGFR1 ligand binding and activation	545
873	19	-1.86788328822199	19	0.4371	0.57144759060105	Dopamine Neurotransmitter Release Cycle	429
899	78	-12.5820696311038	78	0.4373	0.57144759060105	ER-Phagosome pathway	496
1444	27	-3.47440057096112	27	0.4378	0.57144759060105	RNA Pol II CTD phosphorylation and interaction with CE*	1423
358	85	-13.234885369299	85	0.4391	0.57144759060105	Rheumatoid arthritis	1401
177	94	-15.5251985995904	94	0.4393	0.57144759060105	Endocrine resistance	469
515	40	-5.66965559010462	40	0.4397	0.57144759060105	PLK1 signaling events	1224
1611	19	-1.98036743792837	19	0.4401	0.57144759060105	Signaling by FGFR2 IIIa TM	1522
1569	32	-4.18339380431405	32	0.4404	0.57144759060105	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	1587
1157	17	-1.7328086474893	17	0.4409	0.57144759060105	Ligand-dependent caspase activation	879
27	11	-0.542293570565079	11	0.441	0.57144759060105	guanosine ribonucleotides de novo biosynthesis	693
976	48	-7.22105877593294	48	0.4417	0.571735218828986	G alpha (z) signalling events	591
440	33	-4.42249304543089	33	0.4427	0.571949276091432	CXCR3-mediated signaling events	342
1499	85	-14.0444649653985	85	0.443	0.571949276091432	Regulation of PLK1 Activity at G2/M Transition	1354
1202	16	-1.57730346986176	16	0.4433	0.571949276091432	Metabolism of porphyrins	944
1793	68	-10.8469849116192	68	0.4438	0.57197736036382	Triglyceride Biosynthesis	1793
442	44	-6.49814945720352	44	0.4454	0.573421557757157	Calcineurin-regulated NFAT-dependent transcription in lymphocytes	207
272	72	-9.83988217669869	72	0.4478	0.57589148630598	Metabolism of xenobiotics by cytochrome P450	949
1753	88	-15.4219859531051	88	0.4489	0.576323940037356	Toll Like Receptor 9 (TLR9) Cascade*	1727
1594	33	-4.27363194406906	33	0.4491	0.576323940037356	Signal amplification	1501
432	37	-5.57986898604088	37	0.45	0.576717681868193	Aurora B signaling	153
542	30	-4.40138008607407	30	0.4504	0.576717681868193	Signaling events mediated by HDAC Class II	1565
568	28	-4.1687047500166	28	0.4511	0.576717681868193	Trk receptor signaling mediated by the MAPK pathway	1796
1407	166	-29.8800193816444	166	0.4515	0.576717681868193	Programmed Cell Death*	1260
1848	21	-2.68163005363109	21	0.4519	0.576717681868193	mTORC1-mediated signalling	1000
160	14	-1.61425946472568	14	0.4523	0.576717681868193	Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate	291
1161	70	-11.5485134284885	70	0.4547	0.577993299939755	Lipoprotein metabolism	884
911	27	-3.73063249277285	27	0.4549	0.577993299939755	Endogenous sterols	471
1024	24	-1.75338227260945	24	0.4549	0.577993299939755	Glucuronidation	643
250	43	-5.81319745843209	43	0.4554	0.577993299939755	Intestinal immune network for IgA production	834
362	86	-14.7194997428548	86	0.456	0.577993299939755	Salivary secretion	1470
916	146	-24.0190049378044	146	0.4562	0.577993299939755	Epigenetic regulation of gene expression	489
1572	14	-1.42776494538637	14	0.4569	0.578098769807654	STING mediated induction of host immune responses	1611
20	13	-1.26621525262023	13	0.4576	0.578098769807654	fatty acid beta-oxidation (peroxisome)	524
785	71	-8.72346482982836	71	0.4582	0.578098769807654	Condensation of Prophase Chromosomes	317
1726	10	-0.772150063418728	10	0.4583	0.578098769807654	TRIF-mediated programmed cell death	1791
651	26	-3.25411289697896	26	0.4587	0.578098769807654	Adherens junctions interactions	61
411	23	-3.04145235562628	23	0.4592	0.578119730556138	Vitamin digestion and absorption	1851
31	12	-1.19152298356191	12	0.4598	0.57826641199303	leucine degradation	875
703	25	-3.56602107718138	25	0.4617	0.578285841205916	Budding and maturation of HIV virion	197
68	149	-27.1020593483799	136	0.4621	0.578285841205916	Epstein-Barr Virus (dsDNA)	492
317	10	-0.736739174197746	10	0.4624	0.578285841205916	Pentose phosphate pathway (Pentose phosphate cycle)	1162
696	10	-0.7732030708749	10	0.4625	0.578285841205916	Bicarbonate transporters	181
1219	48	-7.83934552549638	48	0.463	0.578285841205916	Mitochondrial biogenesis	968
1221	21	-2.76735245608523	21	0.4631	0.578285841205916	Mitochondrial tRNA aminoacylation	975
1798	98	-17.3809040925912	98	0.4632	0.578285841205916	UCH proteinases	1817
1351	50	-6.24779768658029	50	0.4647	0.579362474187238	Packaging Of Telomere Ends	1141
1341	17	-2.07926490356719	17	0.4654	0.579362474187238	PKA activation in glucagon signalling	1208
964	96	-16.9971103972244	96	0.4656	0.579362474187238	Formation of a pool of free 40S subunits	562
1282	455	-87.4929087139304	455	0.466	0.579362474187238	Neutrophil degranulation	1051
1438	21	-2.85303304980931	21	0.4684	0.580663650370021	RHO GTPases activate PAKs	1409
462	32	-4.93559830653265	32	0.4687	0.580663650370021	EPO signaling pathway	491
1453	145	-24.9193942390382	145	0.4688	0.580663650370021	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	1433
1686	14	-1.37593623953537	14	0.4696	0.580663650370021	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	1647
134	12	-1.2732467135334	12	0.4712	0.580663650370021	Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate	183
1083	12	-1.2824439125528	12	0.4713	0.580663650370021	IRF3-mediated induction of type I IFN	848
1293	12	-1.40211356315107	12	0.4714	0.580663650370021	Notch-HLH transcription pathway	1079
1527	13	-1.50161194771038	13	0.4715	0.580663650370021	Removal of the Flap Intermediate	1374
1763	39	-6.43052329665618	39	0.4717	0.580663650370021	Transcriptional activation of mitochondrial biogenesis	1756
1434	34	-5.58824362252754	34	0.4722	0.580663650370021	RHO GTPases Activate WASPs and WAVEs	1412
950	46	-7.81870002202858	46	0.4728	0.580663650370021	Fatty Acyl-CoA Biosynthesis	531
877	26	-3.98080051284186	26	0.4733	0.580663650370021	Downregulation of TGF-beta receptor signaling	435
827	39	-6.62440142544424	39	0.4737	0.580663650370021	Deactivation of the beta-catenin transactivating complex	367
1266	28	-4.51721144951257	28	0.4739	0.580663650370021	Negative regulation of FGFR3 signaling	1031
1022	76	-13.6778262684033	76	0.475	0.580663650370021	Glucose metabolism	640
1406	14	-1.68755006912533	14	0.475	0.580663650370021	Processive synthesis on the lagging strand	1258
764	100	-16.6174944851198	100	0.4753	0.580663650370021	Chromosome Maintenance	281
620	31	-4.91169219702015	31	0.4771	0.581539308340207	Activation of BH3-only proteins	25
829	53	-9.28548743782921	53	0.4779	0.581539308340207	Deadenylation-dependent mRNA decay	369
1010	25	-3.74372765434344	25	0.4784	0.581539308340207	Gap-filling DNA repair synthesis and ligation in GG-NER	621
1349	71	-9.94310786313435	71	0.4787	0.581539308340207	PRC2 methylates histones and DNA	1240
781	21	-2.87995758770327	21	0.4789	0.581539308340207	Common Pathway of Fibrin Clot Formation	312
850	79	-14.5081013502807	79	0.4796	0.581539308340207	Degradation of beta-catenin by the destruction complex	387
216	23	-3.613403310557	23	0.48	0.581539308340207	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	664
1370	14	-1.62711209464292	14	0.4811	0.581539308340207	Phospholipase C-mediated cascade; FGFR4	1182
1560	17	-2.43765251671521	17	0.4811	0.581539308340207	SHC-mediated cascade:FGFR3	1494
196	13	-1.56670233482536	13	0.4815	0.581539308340207	Folate biosynthesis	560
1549	24	-3.7175723881242	24	0.4818	0.581539308340207	Role of phospholipids in phagocytosis	1455
223	24	-3.89871116263629	24	0.4819	0.581539308340207	Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	673
1451	47	-8.52209166719436	47	0.4828	0.581539308340207	RNA Polymerase I Transcription Initiation	1431
397	35	-6.03984591067667	35	0.4841	0.581539308340207	Tryptophan metabolism	1805
1258	15	-2.0908950222175	15	0.4847	0.581539308340207	NRIF signals cell death from the nucleus	1085
355	20	-2.91713105930773	20	0.4849	0.581539308340207	Renin-angiotensin system	1378
1694	12	-1.56845633556276	12	0.4852	0.581539308340207	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	1666
536	51	-9.42448328116537	51	0.4855	0.581539308340207	Role of Calcineurin-dependent NFAT signaling in lymphocytes	1453
816	47	-8.23447508624138	47	0.4861	0.581539308340207	DNA Damage Bypass	418
5	14	-1.98634183489191	14	0.4862	0.581539308340207	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	358
318	80	-15.0236713823539	80	0.4863	0.581539308340207	Peroxisome	1169
326	71	-12.4952160313489	71	0.4868	0.581539308340207	Platinum drug resistance	1221
902	74	-11.0809652351429	74	0.4872	0.581539308340207	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	504
1240	93	-17.9155810215224	93	0.4887	0.581906617223932	MyD88-independent TLR3/TLR4 cascade*	1009
1662	79	-14.673904591853	79	0.4888	0.581906617223932	Sphingolipid metabolism (REACTOME)	1596
1169	58	-11.0526362307447	58	0.4898	0.581906617223932	MAP kinase activation in TLR cascade	907
1661	41	-7.17784808483351	41	0.4904	0.581906617223932	Sphingolipid de novo biosynthesis	1594
611	16	-2.33229433383467	16	0.4905	0.581906617223932	Acetylcholine Neurotransmitter Release Cycle	14
426	18	-2.89420019603091	18	0.491	0.581906617223932	Arf1 pathway	127
1212	12	-1.23974866618706	12	0.4912	0.581906617223932	Miscellaneous substrates	961
1626	68	-12.9709770161772	68	0.4914	0.581906617223932	Signaling by MET	1538
123	26	-3.1427460826655	26	0.4926	0.58264754954046	Ascorbate and aldarate metabolism	135
1107	25	-4.24561225485982	25	0.493	0.58264754954046	Insulin processing	805
687	23	-3.89790954724253	23	0.4969	0.586098431642711	BBSome-mediated cargo-targeting to cilium	173
1491	22	-3.68176417580742	22	0.4969	0.586098431642711	Regulation of FZD by ubiquitination	1334
941	13	-1.68317107622295	13	0.4984	0.587181351686028	FGFR4 ligand binding and activation	556
1097	128	-24.7800646894648	128	0.4988	0.587181351686028	Influenza Viral RNA Transcription and Replication	791
602	11	-1.31975832272814	11	0.4993	0.587192000780601	ATF6 (ATF6-alpha) activates chaperone genes	146
795	31	-5.36741121544285	31	0.5001	0.58733060849046	Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding	327
821	299	-58.8134092858692	299	0.5004	0.58733060849046	DNA Repair	424
914	27	-4.84674856684866	27	0.5018	0.587478989031853	Energy dependent regulation of mTOR by LKB1-AMPK	476
1237	78	-15.6534333483171	78	0.5019	0.587478989031853	MyD88 cascade initiated on plasma membrane*	1006
1588	107	-18.9318711777306	107	0.502	0.587478989031853	Senescence-Associated Secretory Phenotype (SASP)	1487
595	23	-3.95992646422132	23	0.5057	0.589294112341326	APC/C:Cdc20 mediated degradation of Cyclin B	112
1794	17	-2.93755548247735	17	0.5058	0.589294112341326	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1794
341	162	-31.6123446050851	162	0.5059	0.589294112341326	Purine metabolism (KEGG)	1281
575	22	-3.90296232040403	22	0.5067	0.589294112341326	Visual signal transduction: Rods	1849
230	44	-8.37875118666458	44	0.5069	0.589294112341326	Hedgehog signaling pathway	706
790	15	-2.55120433463119	15	0.5069	0.589294112341326	Constitutive Signaling by NOTCH1 HD Domain Mutants*	322
1256	12	-1.89562795658887	12	0.507	0.589294112341326	NOTCH2 intracellular domain regulates transcription	1083
458	25	-4.38651139535263	25	0.5076	0.589418694540063	EGF receptor (ErbB1) signaling pathway	460
601	25	-4.7152273975394	25	0.5089	0.590355077814277	ATF4 activates genes	145
1764	43	-8.23408452510691	43	0.5126	0.593678890538591	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	1757
707	11	-1.56905420969586	11	0.5128	0.593678890538591	CASP8 activity is inhibited*	225
1813	42	-8.01555477285371	42	0.5153	0.593678890538591	Vasopressin regulates renal water homeostasis via Aquaporins	1832
1423	21	-3.79171128636584	21	0.5154	0.593678890538591	RA biosynthesis pathway	1297
1683	15	-2.54879033951588	15	0.5162	0.593678890538591	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	1661
1035	38	-7.49605650701944	38	0.5163	0.593678890538591	Glycosphingolipid metabolism	672
444	22	-4.03285870909608	22	0.5166	0.593678890538591	Canonical NF-kappaB pathway	215
869	41	-7.93145565656138	41	0.5168	0.593678890538591	Diseases of metabolism	414
1165	12	-1.95016896951569	12	0.5172	0.593678890538591	Lysine catabolism	896
162	27	-5.12320066701542	27	0.5178	0.593678890538591	Collecting duct acid secretion	310
1659	35	-6.9632414113361	35	0.5178	0.593678890538591	Smooth Muscle Contraction	1589
267	26	-4.98371809234469	26	0.5184	0.593678890538591	Maturity onset diabetes of the young	917
1006	18	-2.89860141537013	18	0.5189	0.593678890538591	Gap junction assembly	617
166	258	-51.7558944835108	258	0.5191	0.593678890538591	Cytokine-cytokine receptor interaction	352
619	15	-2.74311551255287	15	0.5193	0.593678890538591	Activation of BAD and translocation to mitochondria	24
865	23	-4.12967069713692	23	0.5202	0.593678890538591	Diseases associated with glycosaminoglycan metabolism	409
695	10	-1.52304984167088	10	0.5205	0.593678890538591	Beta-oxidation of pristanoyl-CoA	180
6	23	-4.3247609223963	23	0.5207	0.593678890538591	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	359
1177	10	-1.47401916200141	10	0.5217	0.594252551558778	MASTL Facilitates Mitotic Progression	916
1470	23	-4.39473291798268	23	0.5229	0.594941840185828	RNA Polymerase III Transcription Termination	1451
882	29	-5.75001319520149	29	0.5233	0.594941840185828	Downstream signaling of activated FGFR2	440
205	15	-2.59504260047256	15	0.5243	0.595512667461752	Gluconeogenesis, oxaloacetate => fructose-6P	639
1143	18	-3.58834551754074	18	0.5249	0.595628512916761	KSRP (KHSRP) binds and destabilizes mRNA	865
992	10	-1.27727782429906	10	0.5268	0.596993107484341	GABA A receptor activation	607
465	13	-2.12277187640367	13	0.5274	0.596993107484341	ErbB receptor signaling network	497
1715	20	-3.843248768698	20	0.5276	0.596993107484341	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	1740
76	19	-3.25608348819191	17	0.5285	0.5974462526243	Human Immunodeficiency Virus type 1 (ssRNA)	752
1096	137	-27.9763554360822	137	0.5296	0.598124419768099	Influenza Life Cycle	790
1513	53	-11.0122350946416	53	0.532	0.599246809747749	Regulation of cholesterol biosynthesis by SREBP (SREBF)	1330
310	93	-19.2064029971741	93	0.5321	0.599246809747749	Pancreatic secretion	1143
1055	18	-3.67889412277996	18	0.5328	0.599246809747749	HS-GAG degradation	746
1512	33	-6.83514581499052	33	0.5331	0.599246809747749	Regulation of beta-cell development	1328
1396	27	-5.37794070001695	27	0.5333	0.599246809747749	Prefoldin mediated transfer of substrate to CCT/TriC	1244
453	128	-26.5358328793143	128	0.5336	0.599246809747749	Direct p53 effectors	406
807	65	-13.4434854253802	65	0.5343	0.599470045454566	Cytosolic sensors of pathogen-associated DNA	355
22	13	-2.2441876189798	13	0.5353	0.599691288397611	gluconeogenesis	637
875	13	-2.46954803563707	13	0.5355	0.599691288397611	Downregulation of ERBB2:ERBB3 signaling	433
580	29	-5.96626163727937	29	0.5361	0.59980159942534	p38 MAPK signaling pathway	1128
3	17	-3.32485295040026	17	0.5375	0.600244950450155	3-phosphoinositide degradation	4
1689	15	-2.97190843897309	15	0.5375	0.600244950450155	Synthesis of glycosylphosphatidylinositol (GPI)	1651
1464	18	-3.53310325625495	18	0.5399	0.602247163303795	RNA Polymerase III Chain Elongation	1445
203	63	-13.4137715652493	63	0.5403	0.602247163303795	Glioma	630
1830	24	-5.04220816606355	24	0.541	0.602465942549521	ZBP1(DAI) mediated induction of type I IFNs	1866
565	24	-4.80114172268818	24	0.543	0.602514413964523	TRAIL signaling pathway	1752
1175	10	-1.86839169042011	10	0.5437	0.602514413964523	MAPK3 (ERK1) activation	914
1433	17	-3.54777690064713	17	0.5441	0.602514413964523	RHO GTPases Activate ROCKs	1411
1195	49	-10.4457798570958	49	0.5447	0.602514413964523	Metabolism of fat-soluble vitamins	937
544	71	-15.2780206459352	71	0.5451	0.602514413964523	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)	1567
783	48	-10.2447640564221	48	0.5451	0.602514413964523	Complex I biogenesis	315
1141	15	-3.12529820827046	15	0.5452	0.602514413964523	JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1	856
627	31	-6.56078432783522	31	0.5459	0.602514413964523	Activation of Kainate Receptors upon glutamate binding	33
380	97	-20.6261723618903	97	0.5467	0.602514413964523	T cell receptor signaling pathway	1668
1781	79	-16.7941697659549	79	0.5467	0.602514413964523	Transport of Mature Transcript to Cytoplasm	1781
415	12	-2.27783203314338	12	0.5471	0.602514413964523	beta-Oxidation	179
213	63	-13.4273304453546	63	0.5479	0.602514413964523	Glycolysis / Gluconeogenesis	660
1765	104	-21.158578639225	104	0.5482	0.602514413964523	Transcriptional regulation by small RNAs	1759
744	488	-101.142601180826	488	0.5483	0.602514413964523	Cell Cycle, Mitotic	245
1620	132	-28.3443124593526	132	0.5486	0.602514413964523	Signaling by Hedgehog	1531
1718	20	-4.31511002457355	20	0.5493	0.602729736587688	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	1734
1774	17	-3.55351695941216	17	0.5502	0.602940146918187	Translesion synthesis by POLK	1769
1727	24	-5.07220790316448	24	0.5505	0.602940146918187	TRP channels	1801
1536	93	-20.1413944962885	93	0.5515	0.603467789999084	Resolution of Sister Chromatid Cohesion	1386
854	66	-13.4407082086533	66	0.5524	0.603467789999084	Deposition of new CENPA-containing nucleosomes at the centromere*	395
636	119	-24.6926237822499	119	0.5525	0.603467789999084	Activation of anterior HOX genes in hindbrain development during early embryogenesis*	21
963	53	-11.7354675973857	53	0.553	0.603467789999084	Formation of TC-NER Pre-Incision Complex	569
102	34	-7.71171787101985	34	0.554	0.604007949681614	African trypanosomiasis	69
1379	30	-6.59955218672671	30	0.5551	0.604656052876719	Platelet calcium homeostasis	1217
734	113	-24.7985903094688	113	0.5558	0.604867663450274	Cap-dependent Translation Initiation*	217
891	24	-5.50361679833326	24	0.5564	0.604970159917175	EGFR downregulation	461
52	13	-2.85198848995305	13	0.5591	0.606778708007399	superpathway of methionine degradation	1627
1412	15	-3.33597958902923	15	0.5594	0.606778708007399	Protein methylation	1271
1324	21	-4.07639167001656	21	0.5599	0.606778708007399	PD-1 signaling	1156
936	10	-1.9682274141091	10	0.5601	0.606778708007399	FGFR2b ligand binding and activation	551
172	66	-14.1901547690332	66	0.5606	0.606778708007399	Drug metabolism - cytochrome P450	444
255	107	-23.4005584106723	107	0.5629	0.607609861714185	Leukocyte transendothelial migration	877
1612	42	-9.35877965716477	42	0.5631	0.607609861714185	Signaling by FGFR2 in disease	1523
493	56	-12.8650997099432	56	0.5633	0.607609861714185	IL4-mediated signaling events	776
975	139	-30.7092010091813	139	0.5634	0.607609861714185	G alpha (s) signalling events	590
632	10	-2.0858817597136	10	0.5655	0.60875741942714	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	38
316	25	-5.75458526434849	25	0.5659	0.60875741942714	Pentose phosphate pathway	1161
62	12	-2.61010120491626	12	0.5662	0.60875741942714	valine degradation	1828
1081	10	-2.08532542000819	10	0.5665	0.60875741942714	IRAK4 deficiency (TLR2/4)*	846
530	19	-4.47983704650832	19	0.569	0.610895031621852	Regulation of cytoplasmic and nuclear SMAD2/3 signaling	1332
700	76	-17.3904754968373	76	0.5701	0.6109791133375	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	189
1310	32	-7.37382909526052	32	0.5701	0.6109791133375	Oncogene Induced Senescence	1106
1342	17	-3.87849823898095	17	0.572	0.61246654799637	PKA-mediated phosphorylation of CREB	1209
137	19	-4.35982435088133	19	0.5735	0.613523406578306	Biosynthesis of unsaturated fatty acids	190
1677	31	-7.16919931039151	31	0.5757	0.615326558597285	Synthesis of PA	1655
1716	13	-3.03362780894296	13	0.5769	0.616058613057538	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	1741
633	10	-2.12288706562836	10	0.578	0.61623963830528	Activation of PUMA and translocation to mitochondria	39
28	24	-5.77886130673335	24	0.5781	0.61623963830528	heparan sulfate biosynthesis	710
120	43	-10.3763451828918	43	0.5792	0.616862421581862	Arginine and proline metabolism	131
1390	954	-202.863337650162	954	0.5808	0.617449509463653	Post-translational protein modification	1234
1030	14	-3.49930946382672	14	0.581	0.617449509463653	Glycogen breakdown (glycogenolysis)	655
1343	39	-9.49626639067915	39	0.5813	0.617449509463653	PKB-mediated events*	1210
1443	77	-17.487498651051	77	0.5824	0.61773313608717	RMTs methylate histone arginines	1421
573	32	-8.05744662989879	32	0.5826	0.61773313608717	Validated transcriptional targets of AP1 family members Fra1 and Fra2	1827
588	25	-6.02298066709582	25	0.5848	0.618949813884182	ADP signalling through P2Y purinoceptor 1	63
1515	21	-5.33759723206183	21	0.5848	0.618949813884182	Regulation of gene expression in beta cells	1336
1463	41	-9.85035306398966	41	0.5853	0.618949813884182	RNA Polymerase III Abortive And Retractive Initiation*	1444
1229	176	-39.7711572375914	176	0.5877	0.620812977754515	Mitotic G2-G2/M phases*	980
89	10	-2.28795153056112	9	0.5881	0.620812977754515	Sindbis Virus (ssRNA)	1582
307	330	-72.9345994047791	330	0.5896	0.621048334747453	PI3K-Akt signaling pathway	1200
1617	40	-9.90556313179635	40	0.59	0.621048334747453	Signaling by FGFR4	1528
376	55	-13.124216465225	55	0.5904	0.621048334747453	Steroid hormone biosynthesis	1609
1061	10	-2.55551778198624	10	0.5904	0.621048334747453	Heme biosynthesis	708
1269	20	-5.26227973876517	20	0.5919	0.621512282922213	Negative regulation of MET activity	1034
502	14	-3.57012176987259	14	0.5923	0.621512282922213	LPA4-mediated signaling events	895
704	17	-4.57536945128696	17	0.5924	0.621512282922213	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	199
1466	36	-8.98872340226193	36	0.5948	0.622684681825937	RNA Polymerase III Transcription Initiation	1447
80	183	-42.6294753135327	167	0.5953	0.622684681825937	Human papillomavirus (dsDNA)	754
1734	33	-8.20635148071962	33	0.5953	0.622684681825937	Termination of translesion DNA synthesis	1685
586	17	-4.1550204384078	17	0.5956	0.622684681825937	ABC transporters in lipid homeostasis	10
1167	290	-64.1816272534503	290	0.5962	0.622767589332674	M Phase	901
1078	23	-6.02277653266885	23	0.5975	0.623245792701407	IKK complex recruitment mediated by RIP1	765
853	14	-3.7564808159967	14	0.5977	0.623245792701407	Depolymerisation of the Nuclear Lamina	394
761	46	-11.7879457691003	46	0.6007	0.624532880446636	Chondroitin sulfate/dermatan sulfate metabolism	278
256	29	-6.95069914080701	29	0.6015	0.624532880446636	Linoleic acid metabolism	882
333	32	-8.00976921401987	32	0.6019	0.624532880446636	Propanoate metabolism	1264
889	41	-10.3534701796892	41	0.6028	0.624532880446636	E3 ubiquitin ligases ubiquitinate target proteins	454
929	13	-3.49692577008728	13	0.6031	0.624532880446636	FCGR activation	541
970	25	-6.63610081101959	25	0.6037	0.624532880446636	Formation of tubulin folding intermediates by CCT/TriC	575
1775	16	-4.27730514448609	16	0.6042	0.624532880446636	Translesion synthesis by REV1	1770
714	29	-7.72870782157311	29	0.6047	0.624532880446636	CDO in myogenesis*	238
1720	16	-4.48358600487224	16	0.6053	0.624532880446636	TRAF3-dependent IRF activation pathway	1744
1388	22	-5.96807553255671	22	0.6064	0.624532880446636	Post-chaperonin tubulin folding pathway	1232
329	32	-8.45003454395631	32	0.6071	0.624532880446636	Primary immunodeficiency	1250
1329	22	-6.00085245959014	22	0.6077	0.624532880446636	PI-3K cascade:FGFR2	1194
639	12	-3.19185037239746	12	0.6083	0.624532880446636	Activation of the TFAP2 (AP-2) family of transcription factors	46
261	51	-13.0407939082404	51	0.6084	0.624532880446636	Lysine degradation	897
1676	22	-5.72720961714674	22	0.6084	0.624532880446636	Synthesis of Leukotrienes (LT) and Eoxins (EX)	1654
239	168	-39.3553072317846	168	0.6087	0.624532880446636	Huntington's disease	757
274	11	-3.12289609123274	11	0.6089	0.624532880446636	Methionine salvage pathway	954
884	26	-6.92976525476993	26	0.609	0.624532880446636	Downstream signaling of activated FGFR4	442
200	29	-7.71528343484396	29	0.6097	0.624532880446636	Galactose metabolism	612
36	27	-7.13887355098097	27	0.6099	0.624532880446636	protein ubiquitylation	1274
1402	29	-7.6372130347152	29	0.6099	0.624532880446636	Processing of Capped Intronless Pre-mRNA	1254
1580	12	-3.198987731361	12	0.6121	0.626249490913161	Scavenging of heme from plasma	1475
396	12	-3.45481481326197	12	0.6127	0.626327580046603	Triacylglycerol biosynthesis	1789
1218	21	-5.72078263650055	21	0.6158	0.628958958015288	Mitochondrial Fatty Acid Beta-Oxidation	969
475	46	-12.3988911638469	46	0.6177	0.629132486504046	FoxO family signaling	579
1783	68	-17.0853428451805	68	0.6178	0.629132486504046	Transport of Mature mRNA derived from an Intron-Containing Transcript	1778
315	34	-9.03689251470317	34	0.6185	0.629132486504046	Pentose and glucuronate interconversions	1160
876	22	-6.11099684633923	22	0.6186	0.629132486504046	Downregulation of SMAD2/3:SMAD4 transcriptional activity	434
1441	20	-5.64448499670561	20	0.6186	0.629132486504046	RIP-mediated NFkB activation via ZBP1	1419
147	121	-29.1905529463344	121	0.6195	0.629146366728573	Cell cycle	242
1063	49	-13.0411265098545	49	0.6206	0.629146366728573	Heparan sulfate/heparin (HS-GAG) metabolism	712
125	49	-13.2749476307164	49	0.622	0.629146366728573	Autoimmune thyroid disease	156
1831	10	-3.0226260546729	10	0.6221	0.629146366728573	Zinc influx into cells by the SLC39 gene family	1867
1776	39	-10.4326087571821	39	0.6229	0.629146366728573	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	1771
1514	12	-3.61306732149982	12	0.6231	0.629146366728573	Regulation of gene expression by Hypoxia-inducible Factor	1335
819	71	-18.0593495240665	71	0.6233	0.629146366728573	DNA Double Strand Break Response*	421
980	29	-7.84890116022077	29	0.6237	0.629146366728573	G-protein activation	595
88	25	-7.16988186951186	23	0.6243	0.629146366728573	Simian Virus 40 (dsDNA)	1581
1767	35	-9.68410969047119	35	0.6243	0.629146366728573	Transcriptional regulation of pluripotent stem cells	1762
473	37	-10.2717234144852	37	0.6244	0.629146366728573	FOXM1 transcription factor network	578
758	12	-3.68329036913433	12	0.6251	0.62932150957915	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	269
1845	16	-4.76605721758908	16	0.6272	0.630648547413148	mRNA decay by 3' to 5' exoribonuclease	990
233	127	-31.0422394819692	127	0.6279	0.630648547413148	Hepatitis C	716
23	16	-4.41204936421962	16	0.628	0.630648547413148	glutathione-mediated detoxification	650
856	10	-3.06653719603916	10	0.6291	0.631223192304502	Dermatan sulfate biosynthesis	398
1362	103	-26.14713391115	103	0.6305	0.631768577860755	Phase 1 - Functionalization of compounds	1173
673	51	-13.5501439496398	51	0.6307	0.631768577860755	Aquaporin-mediated transport	124
1589	155	-37.6528854062889	155	0.6326	0.633141527692917	Separation of Sister Chromatids	1488
175	78	-19.9832301259539	78	0.6341	0.63336436608071	EGFR tyrosine kinase inhibitor resistance	463
402	11	-3.45754886592761	11	0.6352	0.63336436608071	Ubiquinone and other terpenoid-quinone biosynthesis	1812
1353	13	-3.88329861580473	13	0.6353	0.63336436608071	Passive transport by Aquaporins	1147
749	54	-14.5803742362948	54	0.6355	0.63336436608071	Cell-cell junction organization	250
1773	17	-5.17505292165766	17	0.6357	0.63336436608071	Translesion synthesis by POLI	1768
1757	12	-3.75085157438461	12	0.636	0.63336436608071	Trafficking and processing of endosomal TLR	1749
956	10	-3.08897913280411	10	0.6369	0.633732965331525	Folding of actin by CCT/TriC	561
54	15	-4.55342356936443	15	0.6378	0.634100951782256	superpathway of pyrimidine deoxyribonucleoside salvage	1629
548	36	-10.2918528999378	36	0.6384	0.634170314593932	Signaling events mediated by TCPTP	1571
844	17	-5.22998919747892	17	0.6401	0.635331367473894	Defects in vitamin and cofactor metabolism	384
820	161	-39.5793526320984	161	0.6409	0.635436702682939	DNA Double-Strand Break Repair	422
1833	16	-5.15318858055869	16	0.6414	0.635436702682939	activated TAK1 mediates p38 MAPK activation	19
115	68	-18.9924978382081	68	0.6418	0.635436702682939	Antigen processing and presentation	103
35	29	-8.47398973553541	29	0.644	0.635600773950159	phospholipases	1185
1326	28	-8.49461717276287	28	0.6444	0.635600773950159	PERK regulates gene expression	1167
1071	11	-3.68711991387772	11	0.6446	0.635600773950159	Hormone ligand-binding receptors	741
1162	19	-6.05584339582042	19	0.6471	0.635600773950159	Listeria monocytogenes entry into host cells	886
708	21	-6.73366558453459	21	0.6472	0.635600773950159	CD209 (DC-SIGN) signaling	229
1469	28	-8.33894930717327	28	0.6473	0.635600773950159	RNA Polymerase III Transcription Initiation From Type 3 Promoter	1450
66	16	-5.33314763414158	16	0.6482	0.635600773950159	Ebola Virus (ssRNA)	456
1682	46	-13.2502772228406	46	0.6485	0.635600773950159	Synthesis of PIPs at the plasma membrane	1660
313	54	-15.4006224640305	54	0.6488	0.635600773950159	Pathogenic Escherichia coli infection	1148
1700	14	-4.61247063196114	14	0.6492	0.635600773950159	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	1688
405	47	-13.4216445516125	47	0.6497	0.635600773950159	Valine, leucine and isoleucine degradation	1829
1328	21	-6.71185577002454	21	0.6499	0.635600773950159	PI-3K cascade:FGFR1	1193
232	139	-35.2391466701403	139	0.6505	0.635600773950159	Hepatitis B	713
626	18	-5.89512816969626	18	0.6506	0.635600773950159	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	32
584	23	-7.22093983096515	23	0.6507	0.635600773950159	A tetrasaccharide linker sequence is required for GAG synthesis	5
1327	74	-19.805694178649	73	0.6508	0.635600773950159	PI Metabolism	1192
1339	29	-8.7849688326842	29	0.651	0.635600773950159	PIWI-interacting RNA (piRNA) biogenesis	1206
938	12	-4.06392838979868	12	0.6523	0.63631930678082	FGFR3 ligand binding and activation*	553
762	251	-62.0652024180034	251	0.6528	0.63631930678082	Chromatin modifying enzymes*	279
808	19	-6.28487219133368	19	0.6546	0.637327451293497	Cytosolic sulfonation of small molecules	356
1668	27	-8.25121429177193	27	0.6549	0.637327451293497	Surfactant metabolism	1634
253	68	-18.9992756147937	68	0.6558	0.637620033495944	Leishmaniasis	874
815	13	-4.40075363699576	13	0.6563	0.637620033495944	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	402
1846	15	-4.87109145935526	15	0.6568	0.637620033495944	mRNA decay by 5' to 3' exoribonuclease	991
110	43	-12.5943589907905	43	0.6591	0.638912752329955	Aminoacyl-tRNA biosynthesis	91
957	37	-11.2486441984079	37	0.6592	0.638912752329955	Formation of Fibrin Clot (Clotting Cascade)	563
385	22	-7.15096518241124	22	0.6598	0.638976477856037	Terpenoid backbone biosynthesis	1686
817	36	-10.736313621034	36	0.6606	0.639233631489962	DNA Damage Recognition in GG-NER	419
113	50	-14.648823255269	50	0.6625	0.640258098386405	Amyotrophic lateral sclerosis (ALS)	96
1421	25	-7.90745220660282	25	0.6632	0.640258098386405	Pyruvate metabolism (REACTOME)	1295
413	25	-7.84875053157841	25	0.6636	0.640258098386405	alpha-Linolenic acid metabolism	81
1104	14	-4.99960328570351	14	0.6638	0.640258098386405	InlB-mediated entry of Listeria monocytogenes into host cell	799
185	47	-13.7772502251202	47	0.6653	0.64096045356704	Fanconi anemia pathway	519
352	53	-15.1169898185417	53	0.6656	0.64096045356704	Regulation of lipolysis in adipocytes	1347
1607	62	-17.81017870048	62	0.6666	0.64140700425744	Signaling by FGFR in disease	1518
774	128	-33.6062181191483	128	0.6683	0.642525840294972	Clathrin-mediated endocytosis	300
189	21	-6.98203008946239	21	0.6696	0.64261057286439	Fatty acid elongation	527
843	11	-3.97107829618729	11	0.6697	0.64261057286439	Defects in cobalamin (B12) metabolism	383
1519	86	-24.1358094871662	86	0.67	0.64261057286439	Regulation of mRNA stability by proteins that bind AU-rich elements	1349
485	33	-10.5252819321893	33	0.6714	0.642659180557721	IL1-mediated signaling events	768
492	26	-8.57790172014394	26	0.6719	0.642659180557721	IL27-mediated signaling events	775
1369	12	-4.41970203752567	12	0.672	0.642659180557721	Phospholipase C-mediated cascade; FGFR3	1181
342	100	-26.93695304878	100	0.6722	0.642659180557721	Pyrimidine metabolism (KEGG)	1291
1413	58	-16.9201556172039	58	0.6731	0.642778820775571	Protein ubiquitination	1273
1058	97	-26.3945890866293	97	0.6734	0.642778820775571	Hedgehog 'off' state	702
1699	110	-29.7169721137765	110	0.674	0.642838497774187	TCR signaling	1679
1093	361	-86.7153898924411	361	0.6746	0.642898079670017	Infectious disease	784
788	16	-5.76136169182217	16	0.6761	0.643814589513115	Constitutive Signaling by EGFRvIII*	320
1230	166	-42.9224472277211	166	0.6777	0.644824790109186	Mitotic Metaphase and Anaphase*	981
58	30	-9.61982027426732	30	0.6796	0.645210492774511	superpathway of tryptophan utilization	1633
1245	35	-11.1225278777316	35	0.6807	0.645210492774511	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1018
1613	39	-12.2863204453721	39	0.6813	0.645210492774511	Signaling by FGFR3	1524
335	44	-13.8050875433314	44	0.6814	0.645210492774511	Proteasome	1267
1283	15	-5.61005244274091	15	0.6816	0.645210492774511	Nicotinamide salvaging	1056
1467	28	-9.31836553189368	28	0.6826	0.645210492774511	RNA Polymerase III Transcription Initiation From Type 1 Promoter*	1448
1743	23	-7.95264975041673	23	0.6827	0.645210492774511	Thromboxane signalling through TP receptor	1705
1722	24	-8.30287362335135	24	0.6834	0.645210492774511	TRAF6 mediated NF-kB activation	1748
554	21	-7.38565637365285	21	0.6835	0.645210492774511	Sphingosine 1-phosphate (S1P) pathway	1598
1103	12	-4.68927018281133	12	0.6835	0.645210492774511	Initiation of Nuclear Envelope Reformation*	798
1059	82	-23.4714446268321	82	0.6842	0.645230354297252	Hedgehog 'on' state	703
1231	101	-28.058485947086	101	0.6846	0.645230354297252	Mitotic Prometaphase	982
1724	16	-5.90592689479508	16	0.6857	0.645758224300095	TRAF6 mediated induction of TAK1 complex	1746
103	34	-11.0875670578413	34	0.6914	0.650290471961755	Alanine, aspartate and glutamate metabolism	72
654	20	-7.35321582053283	20	0.6916	0.650290471961755	Aflatoxin activation and detoxification	68
939	11	-4.4757610191057	11	0.6922	0.650343357511699	FGFR3 mutant receptor activation*	554
2	27	-9.42388765139523	27	0.6949	0.652367626459242	3-phosphoinositide biosynthesis	3
1566	11	-4.43512006300213	11	0.6977	0.653534475280405	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	1584
968	71	-23.5454757332913	71	0.6979	0.653534475280405	Formation of the cornified envelope	571
973	234	-61.4310104152008	234	0.6985	0.653534475280405	G alpha (i) signalling events	588
1479	11	-4.56182828289046	11	0.6999	0.653534475280405	Recruitment of NuMA to mitotic centrosomes	1314
1690	62	-19.3833389363014	62	0.7001	0.653534475280405	Synthesis of substrates in N-glycan biosythesis	1662
1476	10	-4.30940964642193	10	0.7005	0.653534475280405	Reactions specific to the complex N-glycan synthesis pathway	1309
757	46	-15.3136098373986	46	0.7012	0.653534475280405	Chemokine receptors bind chemokines	266
1176	86	-25.1939887518834	86	0.7019	0.653534475280405	MAPK6/MAPK4 signaling	915
1331	19	-7.18060451915858	19	0.7019	0.653534475280405	PI-3K cascade:FGFR4	1196
918	11	-4.53538568691752	11	0.7023	0.653534475280405	Ethanol oxidation	509
1711	48	-15.347340543812	48	0.7024	0.653534475280405	TP53 Regulates Transcription of Cell Cycle Genes	1736
556	11	-4.64272968995551	11	0.7027	0.653534475280405	Sumoylation by RanBP2 regulates transcriptional repression	1616
141	10	-4.32355940096732	10	0.7041	0.654327713564125	C5 isoprenoid biosynthesis, mevalonate pathway*	204
1040	25	-9.09266374239775	25	0.7051	0.654333120725319	Growth hormone receptor signaling	688
725	12	-5.06224450278641	12	0.7052	0.654333120725319	CS/DS degradation	340
598	70	-21.3721365376974	70	0.7059	0.654474890455931	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	115
294	57	-17.7806290029294	57	0.7071	0.654757771543792	Non-small cell lung cancer	1068
21	11	-4.81389620250024	11	0.7073	0.654757771543792	gamma-linolenate biosynthesis	615
1621	19	-7.29085245466782	19	0.7085	0.654938889572052	Signaling by Hippo	1533
56	12	-5.06418817408578	12	0.7088	0.654938889572052	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1631
878	92	-27.4067178060732	92	0.7096	0.654938889572052	Downstream TCR signaling	443
32	10	-4.23618495770339	10	0.7108	0.654938889572052	melatonin degradation I*	924
375	18	-7.30361858295616	18	0.7109	0.654938889572052	Steroid biosynthesis	1608
1610	73	-22.3688443268331	73	0.7117	0.654938889572052	Signaling by FGFR2	1521
1070	133	-38.1007085181013	133	0.7124	0.654938889572052	Homology Directed Repair*	740
40	10	-4.37752202469777	10	0.713	0.654938889572052	pyrimidine deoxyribonucleotide phosphorylation	1288
1408	16	-6.65112943239339	16	0.7131	0.654938889572052	Prolactin receptor signaling	1261
193	37	-12.7936702304921	37	0.7142	0.654938889572052	Ferroptosis	542
1127	27	-10.075177699498	27	0.7146	0.654938889572052	Interleukin-6 family signaling	830
481	42	-14.5706593912954	42	0.7147	0.654938889572052	Hedgehog signaling events mediated by Gli proteins	705
596	65	-20.4692533265056	65	0.715	0.654938889572052	APC/C:Cdc20 mediated degradation of Securin	114
645	18	-7.40490564434661	18	0.7168	0.654938889572052	Acyl chain remodelling of PG	50
617	74	-22.9388584349581	74	0.7171	0.654938889572052	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins*	22
737	91	-27.138182501664	91	0.7172	0.654938889572052	Cargo recognition for clathrin-mediated endocytosis	223
961	57	-18.2990867363399	57	0.7173	0.654938889572052	Formation of RNA Pol II elongation complex*	567
928	74	-22.8450987344777	74	0.7175	0.654938889572052	FCERI mediated NF-kB activation	539
1080	15	-6.23960313216235	15	0.7179	0.654938889572052	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	845
9	11	-4.76271630787304	11	0.7189	0.65535130121242	NAD de novo biosynthesis	1020
776	21	-8.25820221299224	21	0.7203	0.656127448086156	Cobalamin (Cbl, vitamin B12) transport and metabolism	304
541	62	-20.1639070600623	62	0.721	0.656130011098882	Signaling events mediated by HDAC Class I	1564
1145	12	-5.49982226126123	12	0.7214	0.656130011098882	Keratan sulfate degradation	861
965	35	-12.530647529857	35	0.7236	0.656723685437799	Formation of the Early Elongation Complex*	572
1171	15	-6.39404755778764	15	0.7236	0.656723685437799	MAP3K8 (TPL2)-dependent MAPK1/3 activation	909
1374	12	-5.36196717241196	12	0.7237	0.656723685437799	Physiological factors	1191
1719	13	-5.69704957552568	13	0.7249	0.656864837172797	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	1743
1712	42	-14.75378481341	42	0.7255	0.656864837172797	TP53 Regulates Transcription of Cell Death Genes	1737
152	176	-49.5199499700581	176	0.7259	0.656864837172797	Chemokine signaling pathway	267
1187	86	-29.4125630016333	86	0.7266	0.656864837172797	Meiotic recombination	920
289	28	-10.6369189642227	28	0.7268	0.656864837172797	Nicotinate and nicotinamide metabolism	1057
743	192	-53.6878742484661	192	0.7275	0.656864837172797	Cell Cycle Checkpoints	244
809	24	-9.28055761080993	24	0.7277	0.656864837172797	Cytosolic tRNA aminoacylation	357
30	11	-5.00838160955491	11	0.7284	0.657000848663024	isoleucine degradation	853
641	11	-5.37889243826575	11	0.7294	0.657407044678902	Activation of the phototransduction cascade	44
571	79	-25.2835061791419	79	0.7314	0.658529884103259	Validated targets of C-MYC transcriptional activation	1825
1567	10	-4.76309539365384	10	0.732	0.658529884103259	SLBP independent Processing of Histone Pre-mRNAs	1585
1863	42	-14.831164145424	42	0.7329	0.658529884103259	tRNA Aminoacylation	1797
320	145	-43.1267456199541	145	0.733	0.658529884103259	Phagosome	1171
212	23	-9.18145372316746	23	0.7335	0.658529884103259	Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate	659
771	39	-15.0876755566835	39	0.734	0.658529884103259	Class C/3 (Metabotropic glutamate/pheromone receptors)	295
1717	19	-8.00887912397807	19	0.7345	0.658529884103259	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	1742
1271	10	-4.8019375710488	10	0.7368	0.659275518417738	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	1028
1226	19	-8.01509856490111	19	0.7373	0.659275518417738	Mitophagy*	976
215	19	-8.0420323388668	19	0.7376	0.659275518417738	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	663
1102	21	-9.16314658249969	21	0.7379	0.659275518417738	Initial triggering of complement	797
657	26	-10.2012024645799	26	0.7384	0.659275518417738	Amino acid synthesis and interconversion (transamination)	88
883	24	-9.72235519765268	24	0.739	0.659275518417738	Downstream signaling of activated FGFR3	441
699	215	-62.5105578582118	215	0.7398	0.659275518417738	Biological oxidations	187
63	78	-25.8332177809116	73	0.74	0.659275518417738	Adenovirus (dsDNA)	57
364	15	-6.69151625019034	15	0.7414	0.659275518417738	Selenocompound metabolism	1479
11	10	-4.98457346733813	10	0.7422	0.659275518417738	UTP and CTP de novo biosynthesis	1823
665	291	-76.9475113306112	291	0.7428	0.659275518417738	Antigen processing: Ubiquitination & Proteasome degradation	105
433	28	-11.0004672925398	28	0.7432	0.659275518417738	BARD1 signaling events	166
589	23	-9.59516951175256	23	0.7434	0.659275518417738	ADP signalling through P2Y purinoceptor 12	64
1684	26	-10.4347797124627	26	0.7435	0.659275518417738	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	1645
681	64	-21.479469405806	64	0.7436	0.659275518417738	Asymmetric localization of PCP proteins	143
1320	123	-40.9352901140151	123	0.7472	0.661663628127401	Oxidative Stress Induced Senescence	1124
683	61	-20.739186174628	61	0.7474	0.661663628127401	Autodegradation of Cdh1 by Cdh1:APC/C	154
445	29	-11.611307935991	29	0.7485	0.662109192379378	Canonical Wnt signaling pathway	216
1186	117	-38.9137031279673	117	0.7498	0.662109192379378	Meiosis	919
646	17	-7.94089103807905	17	0.75	0.662109192379378	Acyl chain remodelling of PI	51
1545	11	-5.58893740995164	11	0.7504	0.662109192379378	Reversible hydration of carbon dioxide	1400
1606	86	-27.6216349797426	86	0.7515	0.662109192379378	Signaling by FGFR	1517
952	14	-7.04402246119692	14	0.7525	0.662109192379378	Fatty acids	530
1746	28	-11.3262613393158	28	0.7526	0.662109192379378	Tight junction interactions	1712
1284	26	-10.8268355856732	26	0.7528	0.662109192379378	Nicotinate metabolism	1058
1365	106	-35.7158709241021	106	0.7535	0.662109192379378	Phase II conjugation	1176
1250	12	-6.01362435848006	12	0.7539	0.662109192379378	NF-kB is activated and signals survival	1054
482	11	-5.6567343932227	11	0.7549	0.662109192379378	Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	761
1737	23	-9.88474021170408	23	0.755	0.662109192379378	The canonical retinoid cycle in rods (twilight vision)	1695
609	25	-10.4285301290418	25	0.7551	0.662109192379378	Abortive elongation of HIV-1 transcript in the absence of Tat	12
1578	17	-7.70600942692246	17	0.7565	0.662850820917142	SUMOylation of transcription factors	1620
594	84	-27.4042598257509	84	0.758	0.663678920200952	APC/C-mediated degradation of cell cycle proteins*	111
1696	25	-10.6300067469365	25	0.7607	0.664660754591732	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	1670
37	11	-5.81553121363993	11	0.7608	0.664660754591732	purine deoxyribonucleosides salvage	1280
1864	38	-14.5126108189565	38	0.761	0.664660754591732	tRNA modification in the nucleus and cytosol	1798
86	10	-5.30073577126589	9	0.7616	0.664660754591732	Polyomavirus (dsDNA)	1228
1733	25	-11.2027856400143	25	0.7619	0.664660754591732	Termination of O-glycan biosynthesis	1684
567	32	-12.9009687544326	32	0.7634	0.665385700108879	Trk receptor signaling mediated by PI3K and PLC-gamma	1795
652	28	-11.9165703443106	28	0.7642	0.665385700108879	Adrenaline,noradrenaline inhibits insulin secretion	65
151	78	-29.3778451655338	78	0.7644	0.665385700108879	Chemical carcinogenesis	265
1796	11	-6.022551475363	11	0.7655	0.66585860160546	Tryptophan catabolism	1804
989	90	-31.0492858665866	90	0.7673	0.666750417873612	G2/M DNA damage checkpoint	604
457	69	-24.1568439823582	69	0.7683	0.666750417873612	E2F transcription factor network	452
1576	45	-16.8348928406839	45	0.7692	0.666750417873612	SUMOylation of DNA replication proteins	1618
24	13	-6.484018260198	13	0.7694	0.666750417873612	glycolysis	657
1487	78	-26.5849874337436	78	0.7697	0.666750417873612	Regulation of APC/C activators between G1/S and early anaphase	1326
1298	48	-18.4376743478989	48	0.7701	0.666750417873612	Nuclear Receptor transcription pathway	1092
1020	30	-12.7316840017219	30	0.7707	0.666750417873612	Glucagon-type ligand receptors	635
1740	58	-20.8868967375815	58	0.7711	0.666750417873612	The role of GTSE1 in G2/M progression after G2 checkpoint	1699
1509	36	-14.4240402562544	36	0.7717	0.666750417873612	Regulation of TP53 Expression and Degradation*	1371
983	25	-10.8994916481142	25	0.7721	0.666750417873612	G0 and Early G1	598
73	112	-36.696314078553	105	0.773	0.667045995252896	Herpes Simplex Virus (dsDNA)	720
759	22	-10.2677962149569	22	0.7753	0.667272939424203	Cholesterol biosynthesis	270
1680	18	-8.50267807672524	17	0.7755	0.667272939424203	Synthesis of PIPs at the Golgi membrane	1659
717	95	-31.4213094936174	95	0.7759	0.667272939424203	CLEC7A (Dectin-1) signaling	303
1713	61	-22.4270568625699	61	0.777	0.667272939424203	TP53 Regulates Transcription of DNA Repair Genes	1739
1738	134	-41.839108697222	134	0.7772	0.667272939424203	The citric acid (TCA) cycle and respiratory electron transport	1696
60	16	-7.84413944534643	16	0.7773	0.667272939424203	triacylglycerol biosynthesis	1788
587	101	-34.1691843817221	101	0.778	0.667272939424203	ABC-family proteins mediated transport	11
608	10	-5.84493875024315	10	0.7782	0.667272939424203	Abacavir transport and metabolism	7
392	162	-50.255745958317	162	0.7788	0.667272939424203	Tight junction	1711
291	15	-7.91571166741252	15	0.7793	0.667272939424203	Nitrogen metabolism	1062
236	28	-11.9858289750992	28	0.7794	0.667272939424203	Hippo signaling pathway -multiple species	729
622	13	-6.92147156435008	13	0.7807	0.667907815612208	Activation of DNA fragmentation factor*	27
1457	142	-43.781690677576	142	0.783	0.668295867830598	RNA Polymerase II Transcription	1438
1332	77	-27.2533311784773	77	0.7839	0.668295867830598	PI3K Cascade	1197
420	65	-23.383216000665	65	0.7847	0.668295867830598	p53 signaling pathway	1132
1772	18	-8.91581123401428	18	0.785	0.668295867830598	Translesion Synthesis by POLH	1767
754	427	-117.225638227117	427	0.7854	0.668295867830598	Cellular responses to stress	254
888	10	-5.85046888862526	10	0.7854	0.668295867830598	E2F-enabled inhibition of pre-replication complex formation	453
292	140	-43.3986273474592	140	0.7856	0.668295867830598	Non-alcoholic fatty liver disease (NAFLD)	1065
947	14	-7.71808249904788	14	0.7861	0.668295867830598	Facilitative Na+-independent glucose transporters	517
1294	50	-19.1600663443475	50	0.7867	0.668295867830598	Nuclear Envelope Breakdown	1087
44	17	-8.88014072560161	17	0.7871	0.668295867830598	retinol biosynthesis	1394
1489	26	-12.8718356703905	26	0.7873	0.668295867830598	Regulation of Complement cascade	1331
716	13	-7.24330676924663	13	0.7887	0.66872342338187	CLEC7A (Dectin-1) induces NFAT activation	302
1859	52	-20.0612202717307	52	0.7891	0.66872342338187	rRNA modification in the nucleus and cytosol	1458
647	22	-10.9869601894088	22	0.7895	0.66872342338187	Acyl chain remodelling of PS	52
1303	44	-17.7109199300248	44	0.7909	0.66872342338187	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1097
629	64	-24.0141134861425	64	0.7918	0.66872342338187	Activation of NF-kappaB in B cells	35
347	30	-13.2855410561859	30	0.7934	0.66872342338187	RNA polymerase	1425
356	59	-25.8282021964641	59	0.7941	0.66872342338187	Retinol metabolism	1395
818	77	-31.4422906194018	77	0.7944	0.66872342338187	DNA Damage/Telomere Stress Induced Senescence	420
1048	37	-15.6361972726771	37	0.7963	0.66872342338187	HDR through Single Strand Annealing (SSA)	701
1033	11	-6.87096164416506	11	0.7966	0.66872342338187	Glycoprotein hormones	662
109	47	-19.2086379228518	47	0.7968	0.66872342338187	Amino sugar and nucleotide sugar metabolism	90
1140	42	-17.6970761986916	42	0.7973	0.66872342338187	Iron uptake and transport	849
197	127	-41.1062754443838	127	0.7974	0.66872342338187	FoxO signaling pathway	580
210	86	-30.8656759417404	86	0.7974	0.66872342338187	Glycerophospholipid metabolism	653
520	52	-20.6503691010567	52	0.7978	0.66872342338187	RAC1 signaling pathway	1300
958	44	-18.1879202779167	44	0.7982	0.66872342338187	Formation of HIV elongation complex in the absence of HIV Tat*	564
1060	63	-24.3284044521878	63	0.7995	0.66872342338187	Hedgehog ligand biogenesis	704
1784	43	-17.5570526947869	43	0.7997	0.66872342338187	Transport of Mature mRNAs Derived from Intronless Transcripts*	1780
1435	17	-9.19634093825465	17	0.8006	0.66872342338187	RHO GTPases activate CIT	1404
1599	22	-10.8907810190016	22	0.8006	0.66872342338187	Signaling by BMP	1509
712	11	-6.58138719311319	11	0.8007	0.66872342338187	CDC6 association with the ORC:origin complex	236
1667	24	-11.5392772970937	24	0.8009	0.66872342338187	Sulfur amino acid metabolism	1613
1043	20	-10.3586221209182	20	0.8019	0.66872342338187	HDL-mediated lipid transport	696
1403	93	-34.3697086975509	93	0.8019	0.66872342338187	Processing of DNA double-strand break ends	1255
47	23	-11.3041632025083	23	0.8026	0.66872342338187	superpathway of cholesterol biosynthesis	1621
772	348	-97.1389442678487	348	0.8028	0.66872342338187	Class I MHC mediated antigen processing & presentation	296
1166	34	-14.9279416657829	34	0.8029	0.66872342338187	Lysosome Vesicle Biogenesis	900
751	190	-63.8732016626743	190	0.8036	0.668840676443688	Cellular Senescence	256
1357	13	-7.8410896865273	13	0.8045	0.669124111762962	Peptide hormone biosynthesis	1164
742	585	-154.688084839747	585	0.8075	0.6705530539799	Cell Cycle	243
800	22	-11.2029195155357	22	0.8075	0.6705530539799	Cyclin A/B1 associated events during G2/M transition	345
344	38	-16.8227695217958	38	0.8079	0.6705530539799	Pyruvate metabolism (KEGG)	1294
1201	79	-29.2777299872483	79	0.8087	0.670751573616105	Metabolism of polyamines	943
585	66	-25.8640861116268	66	0.8108	0.672027316267543	ABC transporter disorders	8
1047	10	-6.73655608829881	10	0.8127	0.672401298804939	HDR through MMEJ (alt-NHEJ)	700
1095	147	-47.0066426955305	147	0.8127	0.672401298804939	Influenza Infection	789
618	37	-16.3189906079701	37	0.8132	0.672401298804939	Activation of ATR in response to replication stress	23
582	54	-21.8504589889029	54	0.8135	0.672401298804939	p53 pathway	1131
1073	124	-41.1773547892183	124	0.8144	0.672680317704633	Host Interactions of HIV factors	743
1673	97	-34.3383488463575	97	0.8157	0.673185356890625	Synthesis of DNA	1650
583	54	-21.5759974746534	54	0.8162	0.673185356890625	p75(NTR)-mediated signaling	1138
17	15	-8.55208804732254	15	0.8167	0.673185356890625	chondroitin sulfate biosynthesis	276
1321	62	-24.8327646214841	62	0.8173	0.673215954976128	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	1125
664	93	-34.3957839445395	93	0.819	0.674151965354635	Antigen processing-Cross presentation	104
1027	38	-18.6263798273991	38	0.82	0.674353372041606	Glutathione conjugation	647
1842	182	-57.6413407066859	182	0.8204	0.674353372041606	mRNA Splicing*	993
949	33	-15.3674850255332	33	0.8214	0.674353372041606	Fanconi Anemia Pathway	520
1410	19	-10.5496618830963	19	0.8215	0.674353372041606	Prostacyclin signalling through prostacyclin receptor	1265
1550	123	-41.830152262486	123	0.8223	0.674412673487801	S Phase	1462
1710	11	-7.22997561621854	11	0.8227	0.674412673487801	TP53 Regulates Transcription of Caspase Activators and Caspases	1735
794	43	-19.1038254155814	43	0.8236	0.674688021427577	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	326
1049	218	-67.0727013073045	218	0.8242	0.674717402506025	HIV Infection	733
245	67	-26.0656183919564	67	0.8254	0.675237587288224	Inositol phosphate metabolism (KEGG)	801
1075	16	-9.79993234254261	16	0.8265	0.675622260487813	Hyaluronan metabolism	758
933	27	-13.5814182336999	27	0.827	0.675622260487813	FGFR2 alternative splicing	548
1581	11	-7.23906416974515	11	0.828	0.675977482809483	SeMet incorporation into proteins	1486
79	61	-25.8580493240354	55	0.8286	0.676005884101592	Human T-lymphotropic virus (ssRNART)	756
1397	21	-11.5326220367664	21	0.8304	0.676477713089185	Presynaptic function of Kainate receptors*	1246
1615	21	-11.5189933950354	21	0.8305	0.676477713089185	Signaling by FGFR3 in disease*	1526
1330	17	-9.97319446204133	17	0.8329	0.676477713089185	PI-3K cascade:FGFR3	1195
87	19	-11.4649738993279	17	0.833	0.676477713089185	SARS Coronavirus (ssRNA)	1473
847	55	-23.4894354400673	55	0.8336	0.676477713089185	Degradation of DVL	388
910	17	-10.4074734047242	17	0.8341	0.676477713089185	Elevation of cytosolic Ca2+ levels	467
1180	11	-7.75183549695192	11	0.835	0.676477713089185	MET activates RAS signaling	929
1220	52	-22.1895692783051	52	0.835	0.676477713089185	Mitochondrial protein import	970
1538	93	-34.7624984186995	93	0.8353	0.676477713089185	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	1388
369	43	-19.3949089692582	43	0.8354	0.676477713089185	Sphingolipid metabolism (KEGG)	1595
925	53	-22.7964201195151	53	0.8354	0.676477713089185	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	532
670	11	-7.71278229621634	11	0.8369	0.676779861781295	Apoptotic cleavage of cell adhesion proteins	121
1500	67	-27.6707078040297	67	0.8377	0.676779861781295	Regulation of RAS by GAPs	1357
1304	13	-8.89359080811108	13	0.8385	0.676779861781295	Nucleotide-like (purinergic) receptors	1098
1031	14	-9.09560519806303	14	0.8386	0.676779861781295	Glycogen synthesis	656
1355	30	-15.4137382198532	30	0.8387	0.676779861781295	Pausing and recovery of Tat-mediated HIV elongation*	1151
752	85	-32.8378967025615	85	0.8396	0.676779861781295	Cellular response to heat stress	252
1432	11	-7.94371509363942	11	0.8399	0.676779861781295	RHO GTPases Activate NADPH Oxidases	1408
1789	34	-16.2717057449054	34	0.8403	0.676779861781295	Transport of the SLBP Dependant Mature mRNA*	1784
789	20	-11.5452778825644	20	0.8428	0.677853443524155	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants*	321
1182	10	-7.43762790681552	10	0.8435	0.677853443524155	MET receptor recycling	931
244	162	-57.7621375967268	162	0.8436	0.677853443524155	Influenza A	788
804	65	-29.644142419942	65	0.8439	0.677853443524155	Cytochrome P450 - arranged by substrate type	350
604	53	-23.4967266873637	53	0.8449	0.678198477300897	AUF1 (hnRNP D0) binds and destabilizes mRNA	150
1018	33	-16.1838250082712	33	0.8462	0.678198477300897	Glucagon signaling in metabolic regulation	632
78	13	-9.5963943818786	11	0.8468	0.678198477300897	Human T-lymphotropic virus (dsDNA)	755
678	66	-27.5875666935631	66	0.8471	0.678198477300897	Assembly of the pre-replicative complex	139
270	66	-27.5077348073411	66	0.8478	0.678198477300897	Melanoma	923
268	125	-47.9043542369731	125	0.8484	0.678198477300897	Measles	918
1504	29	-15.5434263755216	29	0.8491	0.678198477300897	Regulation of TP53 Activity through Acetylation	1366
1537	88	-34.3183664957806	88	0.8493	0.678198477300897	Respiratory electron transport	1387
871	72	-30.151728522002	72	0.8495	0.678198477300897	Disorders of transmembrane transporters	416
1037	52	-23.4899801184079	52	0.85	0.678198477300897	Golgi Associated Vesicle Biogenesis	678
644	29	-17.0213802643462	29	0.8545	0.681334413867899	Acyl chain remodelling of PE	49
643	27	-16.1122954565009	27	0.8557	0.681764812935473	Acyl chain remodelling of PC	48
1123	46	-22.6868833278977	46	0.8573	0.681764812935473	Interleukin-10 signaling	826
1118	196	-70.1474626564882	196	0.8582	0.681764812935473	Interferon Signaling	823
912	28	-14.9318034501693	28	0.8586	0.681764812935473	Endosomal Sorting Complex Required For Transport (ESCRT)	473
373	53	-27.7356987310857	53	0.8587	0.681764812935473	Staphylococcus aureus infection	1605
849	58	-26.3726887181968	59	0.8588	0.681764812935473	Degradation of GLI2 by the proteasome*	390
831	57	-25.6152602059919	57	0.8592	0.681764812935473	Dectin-1 mediated noncanonical NF-kB signaling*	371
1865	100	-38.0789213391799	100	0.8596	0.681764812935473	tRNA processing	1799
1079	20	-12.9230522419836	20	0.8616	0.682898200019987	IL-6-type cytokine receptor ligand interactions	767
140	27	-15.8471753393021	27	0.8632	0.683713258654924	Butanoate metabolism	198
1050	140	-49.6553754269282	140	0.8639	0.683814848869722	HIV Life Cycle	734
143	42	-21.1431226617864	42	0.8653	0.683835380030367	Carbohydrate digestion and absorption	218
1053	32	-17.5378394077888	32	0.8659	0.683835380030367	HIV elongation arrest and recovery*	732
398	173	-63.6056722738381	173	0.8664	0.683835380030367	Tuberculosis	1806
680	15	-10.2042356794995	15	0.867	0.683835380030367	Association of licensing factors with the pre-replicative complex	140
59	15	-10.2668335175921	15	0.8678	0.683835380030367	the visual cycle I (vertebrates)	1701
214	10	-7.94807532883705	10	0.8683	0.683835380030367	Glycolysis, core module involving three-carbon compounds	661
642	30	-16.5074854414552	30	0.8683	0.683835380030367	Activation of the pre-replicative complex	45
251	148	-57.9527829260031	148	0.8685	0.683835380030367	Jak-STAT signaling pathway	854
838	59	-27.190364256802	59	0.8695	0.684172345544645	Defective CFTR causes cystic fibrosis	378
1866	56	-25.5173520998155	56	0.8706	0.68458750196303	tRNA processing in the nucleus	1800
479	30	-16.6933710683287	30	0.8724	0.685416179252517	HIF-2-alpha transcription factor network	726
837	17	-13.1421681338064	17	0.8728	0.685416179252517	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)*	377
988	161	-60.5894629663251	161	0.8755	0.687085369421434	G2/M Checkpoints	603
1769	29	-16.8601942688873	29	0.8761	0.687105388049381	Transferrin endocytosis and recycling	1764
1844	50	-23.7470529894752	50	0.8771	0.687438885804089	mRNA Splicing - Minor Pathway	995
304	49	-24.8024451582401	49	0.8781	0.687771946757547	Ovarian steroidogenesis	1121
1065	56	-27.0626829254848	56	0.8791	0.687830460150259	Hh mutants abrogate ligand secretion*	722
1076	12	-10.1625059533427	12	0.8794	0.687830460150259	Hyaluronan uptake and degradation	759
265	44	-23.1059180931309	44	0.8799	0.687830460150259	Malaria	905
1488	51	-25.0090341223492	51	0.8806	0.687928034032077	Regulation of Apoptosis	1327
782	43	-24.9673504797115	43	0.8814	0.688103549916774	Complement cascade	314
1222	92	-38.6003566614578	92	0.8829	0.688161224627765	Mitochondrial translation	971
1223	86	-38.6003566614578	92	0.8829	0.688161224627765	Mitochondrial translation elongation*	972
806	10	-8.38576727032453	10	0.8832	0.688161224627765	Cytosolic iron-sulfur cluster assembly	354
81	105	-43.9939712182091	97	0.8848	0.688959060248954	Influenza virus (ssRNA)	792
1762	344	-108.767030283266	344	0.8871	0.690300565617685	Transcriptional Regulation by TP53	1761
784	11	-9.17760699856433	11	0.888	0.690551618998662	Condensation of Prometaphase Chromosomes	316
1122	41	-22.279412830739	41	0.8891	0.690957774709455	Interleukin-1 signaling	825
753	72	-33.1692273293633	72	0.8906	0.691674058260034	Cellular response to hypoxia*	253
1495	26	-19.7226936229155	26	0.8918	0.692156571884836	Regulation of IFNA signaling	1340
822	104	-42.8277504162815	104	0.8944	0.692204046595444	DNA Replication	426
1108	26	-16.5689764550263	26	0.8944	0.692204046595444	Insulin receptor recycling	806
1556	53	-26.6558607003102	53	0.8948	0.692204046595444	SCF-beta-TrCP mediated degradation of Emi1	1476
1681	13	-10.6810418322435	13	0.8949	0.692204046595444	Synthesis of PIPs at the early endosome membrane	1658
4	16	-11.860872601067	16	0.8971	0.692204046595444	CDP-diacylglycerol biosynthesis	239
1544	33	-18.981565353322	33	0.8977	0.692204046595444	Rev-mediated nuclear export of HIV RNA	1399
1816	42	-22.0770854536473	42	0.898	0.692204046595444	Viral Messenger RNA Synthesis	1844
312	109	-44.902547372014	109	0.8985	0.692204046595444	Parkinson's disease	1146
1401	229	-78.9291010795316	229	0.8985	0.692204046595444	Processing of Capped Intron-Containing Pre-mRNA	1253
736	31	-18.6045747664798	31	0.8986	0.692204046595444	Cargo concentration in the ER	222
848	58	-28.9210550192072	58	0.8991	0.692204046595444	Degradation of GLI1 by the proteasome	389
661	10	-9.57608194128832	10	0.9008	0.692204046595444	Androgen biosynthesis	98
1052	44	-23.8967542503796	44	0.901	0.692204046595444	HIV Transcription Initiation*	736
1344	64	-34.9098033959142	64	0.901	0.692204046595444	PKMTs methylate histone lysines	1211
887	32	-19.1436877844348	32	0.9012	0.692204046595444	E2F mediated regulation of DNA replication	451
75	33	-21.9372603387719	28	0.9013	0.692204046595444	Human Immunodeficiency Virus type 1 (dsDNA)	751
91	11	-9.82295242685561	11	0.9017	0.692204046595444	Varicella Zoster Virus (dsDNA)	1830
1828	24	-20.1143369587043	24	0.9027	0.692289821473171	Xenobiotics	1864
1115	35	-20.1443335440934	35	0.9034	0.692289821473171	Interactions of Rev with host cellular proteins	819
1028	14	-11.8507217440813	14	0.9042	0.692289821473171	Glutathione synthesis and recycling	649
164	76	-38.7479857261473	76	0.9052	0.692289821473171	Complement and coagulation cascades	313
1822	50	-26.6201631213333	50	0.906	0.692289821473171	Vpu mediated degradation of CD4	1856
378	10	-9.52354945194812	10	0.9062	0.692289821473171	Synthesis and degradation of ketone bodies	1642
715	57	-29.2437756774198	57	0.9071	0.692289821473171	CDT1 association with the CDC6:ORC:origin complex	240
985	63	-30.8958707482606	63	0.9073	0.692289821473171	G1/S DNA Damage Checkpoints*	600
1199	51	-26.1037621672202	51	0.9073	0.692289821473171	Metabolism of non-coding RNA*	941
1815	50	-26.7052715403687	50	0.9076	0.692289821473171	Vif-mediated degradation of APOBEC3G	1842
846	53	-27.8391177058771	53	0.9087	0.692687103459427	Degradation of AXIN	386
1522	49	-26.8189210160404	49	0.9099	0.693160059160459	Regulation of ornithine decarboxylase (ODC)	1352
1299	32	-19.3970527499068	32	0.9115	0.693936938014447	Nuclear import of Rev protein	1090
1455	77	-36.8295587906364	77	0.9125	0.694184222752799	RNA Polymerase II Pre-transcription Events	1435
1234	12	-11.0652868165594	12	0.9131	0.694184222752799	Mitotic Telophase/Cytokinesis	985
1674	10	-9.58013026373859	10	0.9137	0.694184222752799	Synthesis of IP2, IP, and Ins in the cytosol	1652
1347	12	-10.7772554666782	12	0.9142	0.694184222752799	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	1237
1297	34	-20.2711705656956	34	0.9156	0.694184222752799	Nuclear Pore Complex (NPC) Disassembly	1091
305	100	-44.1007139966888	100	0.9168	0.694184222752799	Oxidative phosphorylation	1123
57	11	-10.9579658850702	11	0.9169	0.694184222752799	superpathway of steroid hormone biosynthesis	1632
1506	19	-14.8784813028064	19	0.9178	0.694184222752799	Regulation of TP53 Activity through Methylation	1368
1841	10	-10.7788687603496	10	0.9181	0.694184222752799	mRNA Editing	992
98	20	-15.8309324815456	20	0.919	0.694184222752799	Adenine ribonucleotide biosynthesis, IMP => ADP,ATP	55
731	10	-10.4323986466033	10	0.919	0.694184222752799	Calcitonin-like ligand receptors	208
1142	10	-9.83982461673251	10	0.9198	0.694184222752799	Josephin domain DUBs	858
733	26	-17.6807286563078	26	0.9216	0.694184222752799	Calnexin/calreticulin cycle	212
798	12	-12.8367958518473	12	0.923	0.694184222752799	Creation of C4 and C2 activators	335
252	53	-29.5308600946837	53	0.9233	0.694184222752799	Legionellosis	873
1853	51	-28.5635376286181	51	0.9233	0.694184222752799	p53-Independent DNA Damage Response*	1135
393	99	-49.5139668896758	99	0.9243	0.694184222752799	Toll-like receptor signaling pathway	1730
1573	99	-45.8584631335156	99	0.9243	0.694184222752799	SUMO E3 ligases SUMOylate target proteins	1614
1516	15	-12.9673275751528	15	0.9246	0.694184222752799	Regulation of innate immune responses to cytosolic DNA	1342
45	11	-11.922489103907	11	0.9259	0.694184222752799	stearate biosynthesis	1607
1155	127	-53.3282585471689	127	0.9263	0.694184222752799	Late Phase of HIV Life Cycle	870
1574	105	-47.7875496469086	105	0.9269	0.694184222752799	SUMOylation	1615
727	11	-14.5139706729844	11	0.9278	0.694184222752799	CYP2E1 reactions	348
1575	73	-37.3089006474296	73	0.9287	0.694184222752799	SUMOylation of DNA damage response and repair proteins	1617
1721	35	-28.3424216509149	35	0.9293	0.694184222752799	TRAF6 mediated IRF7 activation	1747
553	34	-22.3842969759775	34	0.9298	0.694184222752799	Signaling mediated by p38-alpha and p38-beta	1575
18	12	-11.5393928065279	12	0.93	0.694184222752799	dermatan sulfate biosynthesis	397
1099	11	-10.9495027824197	11	0.93	0.694184222752799	Inhibition of replication initiation of damaged DNA by RB1/E2F1	794
138	39	-23.7793767910375	39	0.9308	0.694184222752799	Bladder cancer	192
1204	30	-21.2403104207681	30	0.9308	0.694184222752799	Metabolism of steroid hormones	946
437	22	-17.0649136763967	22	0.9312	0.694184222752799	C-MYC pathway	202
922	31	-20.4297053679452	31	0.9312	0.694184222752799	Export of Viral Ribonucleoproteins from Nucleus*	514
343	11	-12.2643624214832	11	0.9315	0.694184222752799	Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP	1293
238	35	-22.7958836837103	35	0.9323	0.694184222752799	Homologous recombination	739
1760	66	-35.1172038997402	66	0.9326	0.694184222752799	Transcription of the HIV genome	1754
1179	11	-11.2610489646066	11	0.9328	0.694184222752799	MET activates RAP1 and RAC1	928
1116	33	-21.4227743524052	33	0.9333	0.694184222752799	Interactions of Vpr with host cellular proteins*	820
1664	52	-30.0217668766842	52	0.9342	0.694361902070142	Stabilization of p53	1604
1618	11	-11.5570248863821	11	0.9347	0.694361902070142	Signaling by FGFR4 in disease	1529
69	16	-13.9738865368734	16	0.9357	0.694673299375955	Hepatitis B virus (dsDNA)	714
1492	30	-20.3858188760588	30	0.9371	0.695281090224002	Regulation of Glucokinase by Glucokinase Regulatory Protein	1337
640	56	-32.0858467054197	57	0.9393	0.69602918465321	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S*	43
227	13	-13.7444538700688	13	0.9394	0.69602918465321	Guanine ribonucleotide biosynthesis IMP => GDP,GTP	690
49	12	-12.812685583216	12	0.9403	0.69602918465321	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1624
773	68	-36.6988147796488	68	0.9411	0.69602918465321	Clathrin derived vesicle budding*	299
962	16	-14.9177628497781	16	0.9411	0.69602918465321	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	568
1785	30	-20.9364996477385	30	0.9416	0.69602918465321	Transport of Ribonucleoproteins into the Host Nucleus	1783
1490	74	-39.2402904696201	74	0.9426	0.696338013422254	Regulation of DNA replication*	1333
897	21	-17.1530311366774	21	0.9434	0.696498803765442	ER Quality Control Compartment (ERQC)	494
1473	32	-23.0100673612477	32	0.9457	0.697630902649012	ROS, RNS production in phagocytes	1457
799	48	-30.1832371433487	48	0.9461	0.697630902649012	Cross-presentation of soluble exogenous antigens (endosomes)	339
219	18	-17.8498944063853	18	0.947	0.697864291289131	Glycosaminoglycan degradation	667
363	82	-44.712853155519	82	0.9477	0.697950099036621	Salmonella infection	1472
1094	17	-15.3534544137817	17	0.9484	0.698035801174577	Inflammasomes	785
823	81	-42.6370949635002	81	0.9493	0.698268510193264	DNA Replication Pre-Initiation*	427
1736	12	-12.8655679065709	12	0.9507	0.69886848784307	The NLRP3 inflammasome	1697
1614	10	-12.0264704072527	10	0.952	0.699111764372791	Signaling by FGFR3 fusions in cancer	1525
1857	15	-15.2528150151888	15	0.9522	0.699111764372791	p75NTR signals via NF-kB	1140
302	18	-16.5832482764793	18	0.9528	0.699123115300808	Other glycan degradation	1118
756	95	-50.3731153191573	95	0.9586	0.702947646301886	Chaperonin-mediated protein folding	264
1411	101	-52.7866091947975	101	0.9599	0.703413749220647	Protein folding	1270
1856	12	-14.2241950054236	12	0.9609	0.703413749220647	p75NTR recruits signalling complexes	1139
969	48	-31.36587153313	48	0.961	0.703413749220647	Formation of the ternary complex, and subsequently, the 43S complex	574
1471	66	-39.1991306385578	66	0.9625	0.704080795516293	RNA polymerase II transcribes snRNA genes	1437
132	41	-30.0063601572185	41	0.9636	0.704454600199906	Basal transcription factors	168
90	51	-35.7505914744539	47	0.9659	0.705704690738567	Vaccinia Virus (dsDNA)	1824
1493	67	-40.4953979235212	67	0.9665	0.705711961243025	Regulation of HSF1-mediated heat shock response	1338
1147	212	-149.787629831554	212	0.968	0.706184951417114	Keratinization	863
71	18	-20.859084006988	16	0.9685	0.706184951417114	Hepatitis C Virus (dsDNA)	717
65	35	-31.4207879339284	31	0.969	0.706184951417114	Dengue Fever Virus (ssRNA)	392
1194	278	-111.546916173322	278	0.97	0.706184951417114	Metabolism of carbohydrates	936
1555	58	-37.8971990869543	58	0.9701	0.706184951417114	SCF(Skp2)-mediated degradation of p27/p21	1477
1503	155	-74.0413514727056	155	0.9723	0.707355915872344	Regulation of TP53 Activity	1365
1440	81	-56.0754850983982	81	0.973	0.707434858217232	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	1418
803	69	-43.7471342967822	71	0.9738	0.707586367033253	Cyclin E associated events during G1/S transition*	347
1064	53	-35.9995213295133	53	0.9745	0.707665073594383	Hexose transport	721
997	932	-352.205214672773	925	0.9758	0.708112321128605	GPCR downstream signaling	681
1016	812	-299.881760407575	811	0.9763	0.708112321128605	Generic Transcription Pathway	628
285	161	-91.5991164555905	161	0.9777	0.708324977397895	NOD-like receptor signaling pathway	1063
1069	42	-32.9882474759393	42	0.9787	0.708324977397895	Homologous DNA Pairing and Strand Exchange	738
679	39	-32.0649169963392	39	0.9792	0.708324977397895	Association of TriC/CCT with target proteins during biosynthesis	141
858	273	-130.127389560376	273	0.9806	0.708324977397895	Deubiquitination	400
1023	45	-34.2739291223067	45	0.981	0.708324977397895	Glucose transport	641
345	65	-57.9256519862521	65	0.9814	0.708324977397895	RIG-I-like receptor signaling pathway	1417
167	61	-54.9945648330528	61	0.9821	0.708324977397895	Cytosolic DNA-sensing pathway	353
667	75	-47.5913064445887	75	0.9821	0.708324977397895	Antiviral mechanism by IFN-stimulated genes*	107
1399	39	-32.8680412878168	39	0.9826	0.708324977397895	Presynaptic phase of homologous DNA pairing and strand exchange	1248
986	113	-63.4791414366012	113	0.9831	0.708324977397895	G1/S Transition	601
1577	47	-38.3870279578185	47	0.9836	0.708324977397895	SUMOylation of RNA binding proteins	1619
684	49	-40.7985950063565	54	0.9837	0.708324977397895	Autodegradation of the E3 ubiquitin ligase COP1*	155
1046	67	-45.0153956419233	67	0.9845	0.708419126043386	HDR through Homologous Recombination (HRR)	699
1273	35	-31.0422103012535	35	0.9855	0.708419126043386	Negative regulators of RIG-I/MDA5 signaling	1037
374	33	-35.0937081853002	33	0.9859	0.708419126043386	Starch and sucrose metabolism	1606
1533	34	-31.395484212515	34	0.9862	0.708419126043386	Resolution of D-Loop Structures*	1383
1672	23	-25.8739810442342	23	0.9873	0.708783595510292	Synthesis and interconversion of nucleotide di- and triphosphates	1643
1535	26	-27.6566341626195	26	0.9879	0.7087888925598	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	1385
1799	205	-130.628425730085	205	0.9922	0.711068023769857	Ub-specific processing proteases	1811
263	118	-69.4001496473018	118	0.9925	0.711068023769857	Lysosome	899
1507	89	-61.9854098323084	89	0.9929	0.711068023769857	Regulation of TP53 Activity through Phosphorylation	1369
1228	137	-82.6183478954372	137	0.9951	0.711068023769857	Mitotic G1-G1/S phases	979
666	91	-117.296609469455	91	0.9952	0.711068023769857	Antimicrobial peptides	106
706	137	-88.6443422520398	137	0.9957	0.711068023769857	C-type lectin receptors (CLRs)	203
1074	40	-39.9667869071868	40	0.9961	0.711068023769857	Host Interactions with Influenza Factors*	744
298	406	-300.572894980794	398	0.9964	0.711068023769857	Olfactory transduction	1105
845	48	-114.169317579199	48	0.9968	0.711068023769857	Defensins	385
1309	380	-316.215289593918	373	0.9972	0.711068023769857	Olfactory Signaling Pathway	1104
832	28	-47.7329738395955	28	0.998	0.711068023769857	Dectin-2 family	372
802	38	-44.9852421788471	38	0.9986	0.711068023769857	Cyclin D associated events in G1*	346
692	39	-115.392777149803	39	0.9992	0.711068023769857	Beta defensins	175
348	154	-107.962082562623	154	0.9994	0.711068023769857	RNA transport	1452
